7Baggers

Jazz Pharmaceuticals plc
(NASDAQ:JAZZ) 

JAZZ stock logo

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuros...

Founded: 2005
Full Time Employees: 1,620
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 
                                                                               
      revenues:
                                                                               
      product sales
    1,132,448,000 1,064,412,000 985,571,000 839,418,000 1,025,211,000 989,707,000 964,144,000 842,102,000 967,339,000 938,398,000 946,987,000 884,219,000 967,526,000 935,766,000 928,300,000 809,837,000 892,883,000 834,247,000 748,340,000 603,531,000 661,303,000 596,949,000 558,203,000 530,205,000 576,526,000 532,321,000 523,423,000 503,331,000 467,334,000 465,197,000 496,095,000 440,847,000 430,095,000 407,971,000 389,655,000 373,678,000 392,614,000 371,621,000 379,110,000 333,916,000 338,924,000 338,754,000 332,106,000 307,035,000 324,223,000 304,407,000 289,100,000 244,986,000 233,796,000 230,386,000 206,564,000 194,652,000 181,942,000 174,130,000 128,310,000 107,336,000 80,935,000 72,216,000 63,464,000 49,903,000 52,357,000 43,838,000 39,528,000 34,283,000 37,319,000 29,992,000 26,478,000 21,319,000 18,880,000 17,022,000 14,751,000 13,984,000 14,860,000 13,436,000 13,615,000 
      royalties and contract revenues
    65,478,000 61,695,000 60,141,000 58,423,000 62,962,000 65,262,000 59,681,000 59,881,000 44,596,000 33,742,000 10,330,000 8,593,000 4,597,000 4,886,000 4,578,000 3,884,000 3,848,000 3,868,000 3,471,000 4,050,000 4,214,000 3,939,000 4,233,000 4,521,000 5,214,000 5,381,000 10,710,000 4,855,000 9,123,000 4,176,000 4,384,000 3,766,000 6,304,000 3,884,000 4,731,000 2,375,000 4,007,000 2,560,000 2,051,000 2,094,000 1,957,000 2,118,000 1,641,000 2,268,000 3,919,000 2,177,000 2,130,000 1,933,000 1,978,000 1,774,000 1,688,000 1,585,000 1,761,000 1,385,000 1,229,000 1,078,000                    
      total revenues
    1,197,926,000 1,126,107,000 1,045,712,000 897,841,000 1,088,173,000 1,054,969,000 1,023,825,000 901,983,000 1,011,935,000 972,140,000 957,317,000 892,812,000 972,123,000 940,652,000 932,878,000 813,721,000 896,731,000 838,115,000 751,811,000 607,581,000 665,517,000 600,888,000 562,436,000 534,726,000 581,740,000 537,702,000 534,133,000 508,186,000 476,457,000 469,373,000 500,479,000 444,613,000 436,399,000 411,855,000 394,386,000 376,053,000 396,621,000 374,181,000 381,161,000 336,010,000 340,881,000 340,872,000 333,747,000 309,303,000 328,142,000 306,584,000 291,230,000 246,919,000 235,774,000 232,160,000 208,252,000 196,237,000 183,703,000 175,515,000 129,539,000 108,414,000 83,536,000 73,293,000 64,567,000 50,881,000 53,369,000 44,753,000 40,486,000 35,173,000 38,284,000 30,809,000 37,280,000 22,076,000 19,595,000 17,746,000 15,539,000 14,634,000 15,477,000 21,474,000 14,264,000 
      yoy
    10.09% 6.74% 2.14% -0.46% 7.53% 8.52% 6.95% 1.03% 4.10% 3.35% 2.62% 9.72% 8.41% 12.23% 24.08% 33.93% 34.74% 39.48% 33.67% 13.62% 14.40% 11.75% 5.30% 5.22% 22.10% 14.56% 6.72% 14.30% 9.18% 13.97% 26.90% 18.23% 10.03% 10.07% 3.47% 11.92% 16.35% 9.77% 14.21% 8.63% 3.88% 11.18% 14.60% 25.26% 39.18% 32.06% 39.84% 25.83% 28.35% 32.27% 60.76% 81.01% 119.91% 139.47% 100.63% 113.07% 56.53% 63.77% 59.48% 44.66% 39.40% 45.26% 8.60% 59.33% 95.38% 73.61% 139.91% 50.85% 26.61% -17.36% 8.94%     
      qoq
    6.38% 7.69% 16.47% -17.49% 3.15% 3.04% 13.51% -10.87% 4.09% 1.55% 7.22% -8.16% 3.35% 0.83% 14.64% -9.26% 6.99% 11.48% 23.74% -8.71% 10.76% 6.84% 5.18% -8.08% 8.19% 0.67% 5.11% 6.66% 1.51% -6.22% 12.57% 1.88% 5.96% 4.43% 4.88% -5.19% 6.00% -1.83% 13.44% -1.43% 0.00% 2.13% 7.90% -5.74% 7.03% 5.27% 17.95% 4.73% 1.56% 11.48% 6.12% 6.82% 4.67% 35.49% 19.49% 29.78% 13.98% 13.51% 26.90% -4.66% 19.25% 10.54% 15.11% -8.13% 24.26% -17.36% 68.87% 12.66% 10.42% 14.20% 6.18% -5.45% -27.93% 50.55%  
      operating expenses:
                                                                               
      cost of product sales
    153,528,000 128,880,000 116,268,000 104,620,000 128,713,000 111,611,000 109,902,000 95,487,000 107,243,000 102,153,000 97,537,000 128,644,000 167,364,000 133,661,000 124,208,000 115,284,000 136,153,000 145,224,000 119,194,000 40,189,000 50,157,000 42,095,000 28,008,000 28,657,000 35,348,000 31,400,000 27,676,000 33,506,000 26,337,000 26,574,000 34,714,000 33,919,000 25,248,000 31,203,000 28,672,000 25,065,000 33,656,000 24,311,000 23,980,000 23,439,000 24,030,000 28,385,000 21,813,000 28,298,000 28,808,000 26,994,000 30,692,000 30,924,000 25,643,000 24,252,000 25,031,000 27,220,000 25,763,000 32,629,000 15,370,000 10,758,000 3,862,000 3,901,000 3,370,000 2,809,000 4,784,000 3,091,000 2,802,000 2,882,000 2,782,000 2,338,000 2,575,000 1,943,000 3,305,000 5,525,000 2,796,000 2,298,000 3,283,000 1,938,000 1,679,000 
      selling, general and administrative
    406,212,000 530,647,000 358,399,000 514,013,000 369,287,000 325,772,000 338,523,000 351,712,000 396,034,000 308,310,000 340,844,000 297,917,000 383,203,000 358,478,000 366,473,000 308,813,000 398,462,000 363,682,000 429,031,000 260,508,000 247,172,000 207,255,000 191,406,000 208,400,000 214,275,000 178,706,000 176,014,000 167,947,000 161,865,000 155,873,000 158,579,000 207,213,000 143,050,000 124,523,000 132,328,000 144,255,000 127,141,000 124,368,000 122,618,000 128,765,000 125,555,000 104,044,000 107,132,000 112,388,000 105,694,000 93,501,000 100,556,000 106,363,000 81,299,000 74,970,000 77,506,000 70,528,000 61,377,000 60,924,000 60,638,000 46,999,000 36,384,000 30,547,000 22,094,000 19,911,000 17,070,000 18,040,000 17,096,000 16,790,000 15,718,000 15,061,000 13,657,000 14,216,000 20,183,000 24,329,000 34,109,000 32,780,000 27,957,000 18,069,000 18,175,000 
      research and development
    213,909,000 198,203,000 189,972,000 180,652,000 240,500,000 199,919,000 220,734,000 222,847,000 216,608,000 234,402,000 209,238,000 189,410,000 172,555,000 148,870,000 139,047,000 129,981,000 155,443,000 141,036,000 132,696,000 76,573,000 91,699,000 78,647,000 78,922,000 86,107,000 97,382,000 79,855,000 62,384,000 60,105,000 56,657,000 51,160,000 56,132,000 62,667,000 65,995,000 47,362,000 40,157,000 44,928,000 44,158,000 47,796,000 39,091,000 31,252,000 29,455,000 50,784,000 27,833,000 27,181,000 24,559,000 22,423,000 20,090,000 18,109,000 13,809,000 12,814,000 9,250,000 10,747,000 7,277,000 6,920,000 2,321,000 3,959,000 3,764,000 3,279,000 3,382,000 3,695,000 4,118,000 7,317,000 7,962,000 6,215,000 6,317,000 7,644,000 11,192,000 11,408,000 14,689,000 12,149,000 21,882,000 21,243,000 20,540,000 16,978,000 17,407,000 
      intangible asset amortization
    169,742,000 168,368,000 162,103,000 154,448,000 158,903,000 157,457,000 155,223,000 155,730,000 151,553,000 154,883,000 152,062,000 149,786,000 137,387,000 141,232,000 148,456,000 172,094,000 157,293,000 159,804,000 140,480,000 68,192,000 67,075,000 66,684,000 62,974,000 62,847,000 173,490,000 62,863,000 61,576,000 56,885,000 46,543,000 46,989,000 54,959,000 53,007,000 52,901,000 47,313,000 26,186,000 25,665,000 26,162,000 26,453,000 26,737,000 22,642,000 23,690,000 26,127,000 23,668,000 24,677,000 31,977,000 30,630,000 32,795,000 31,182,000 20,524,000 19,564,000 19,399,000 19,555,000 21,907,000 19,742,000 15,751,000 13,513,000 1,862,000 1,862,000 1,862,000 1,862,000 1,862,000 1,862,000 2,044,000 2,057,000            
      acquired in-process research and development
     42,500,000 905,362,000     10,000,000 18,000,000   1,000,000 375,000,000  69,148,000      36,000,000 10,000,000 3,000,000 202,250,000  51,775,000 2,200,000 56,000,000     8,000,000 75,000,000 2,000,000   15,000,000  8,750,000     626,000 75,000,000  127,000,000                            
      total operating expenses
    943,391,000 1,068,598,000 1,732,104,000 953,733,000 897,403,000 794,759,000 824,382,000 835,776,000 889,438,000 799,748,000 799,681,000 766,757,000 1,235,509,000 915,889,000 847,332,000 726,172,000 847,351,000 809,746,000 821,401,000 445,462,000 492,103,000 404,681,000 364,310,000 724,400,000 520,495,000 404,599,000 329,850,000 374,443,000 291,402,000 280,596,000 347,280,000 356,806,000 295,194,000 325,401,000 229,343,000 239,913,000 231,117,000 237,928,000 212,426,000 214,848,000 234,253,000 209,340,000 180,446,000 192,544,000 198,223,000 248,548,000 216,939,000 313,578,000 141,275,000 131,600,000 131,186,000 128,050,000 116,324,000 120,215,000 94,080,000 75,229,000 45,872,000 39,589,000 30,708,000 28,277,000 27,834,000 30,310,000 29,904,000 27,944,000 26,874,000 27,100,000 29,246,000 29,299,000 71,314,000 45,490,000 62,633,000 58,442,000 74,221,000 39,272,000 57,017,000 
      income from operations
    254,535,000 57,509,000 -686,392,000 -55,892,000 190,770,000 260,210,000 199,443,000 66,207,000 122,497,000 172,392,000 157,636,000 126,055,000 -263,386,000 24,763,000 85,546,000 87,549,000 49,380,000 28,369,000 -69,590,000 162,119,000 173,414,000 196,207,000 198,126,000 -189,674,000 61,245,000 133,103,000 204,283,000 133,743,000 185,055,000 188,777,000 153,199,000 87,807,000 141,205,000 86,454,000 165,043,000 136,140,000 165,504,000 136,253,000 168,735,000 121,162,000 106,628,000 131,532,000 153,301,000 116,759,000 129,919,000 58,036,000 74,291,000 -66,659,000 94,499,000 100,560,000 77,066,000 68,187,000 67,379,000 55,300,000 35,459,000 33,185,000 37,664,000 33,704,000 33,859,000 22,604,000 25,535,000 14,443,000 10,582,000 7,229,000 11,410,000 3,709,000 8,034,000 -7,223,000 -51,719,000 -27,744,000 -47,094,000 -43,808,000 -58,744,000 -17,798,000 -42,753,000 
      yoy
    33.43% -77.90% -444.15% -184.42% 55.73% 50.94% 26.52% -47.48% -146.51% 596.17% 84.27% 43.98% -633.39% -12.71% -222.93% -46.00% -71.52% -85.54% -135.12% -185.47% 183.15% 47.41% -3.01% -241.82% -66.90% -29.49% 33.34% 52.31% 31.05% 118.36% -7.18% -35.50% -14.68% -36.55% -2.19% 12.36% 55.22% 3.59% 10.07% 3.77% -17.93% 126.64% 106.35% -275.16% 37.48% -42.29% -3.60% -197.76% 40.25% 81.84% 117.34% 105.48% 78.89% 64.08% 4.73% 46.81% 47.50% 133.36% 219.97% 212.69% 123.79% 289.40% 31.72% -200.08% -122.06% -113.37% -117.06% -83.51% -11.96% 55.88% 10.15%     
      qoq
    342.60% -108.38% 1128.07% -129.30% -26.69% 30.47% 201.24% -45.95% -28.94% 9.36% 25.05% -147.86% -1163.63% -71.05% -2.29% 77.30% 74.06% -140.77% -142.93% -6.51% -11.62% -0.97% -204.46% -409.70% -53.99% -34.84% 52.74% -27.73% -1.97% 23.22% 74.47% -37.82% 63.33% -47.62% 21.23% -17.74% 21.47% -19.25% 39.26% 13.63% -18.93% -14.20% 31.30% -10.13% 123.86% -21.88% -211.45% -170.54% -6.03% 30.49% 13.02% 1.20% 21.84% 55.95% 6.85% -11.89% 11.75% -0.46% 49.79% -11.48% 76.80% 36.49% 46.38% -36.64% 207.63% -53.83% -211.23% -86.03% 86.42% -41.09% 7.50% -25.43% 230.06% -58.37%  
      operating margin %
    21.25% 5.11% -65.64% -6.23% 17.53% 24.67% 19.48% 7.34% 12.11% 17.73% 16.47% 14.12% -27.09% 2.63% 9.17% 10.76% 5.51% 3.38% -9.26% 26.68% 26.06% 32.65% 35.23% -35.47% 10.53% 24.75% 38.25% 26.32% 38.84% 40.22% 30.61% 19.75% 32.36% 20.99% 41.85% 36.20% 41.73% 36.41% 44.27% 36.06% 31.28% 38.59% 45.93% 37.75% 39.59% 18.93% 25.51% -27.00% 40.08% 43.31% 37.01% 34.75% 36.68% 31.51% 27.37% 30.61% 45.09% 45.99% 52.44% 44.43% 47.85% 32.27% 26.14% 20.55% 29.80% 12.04% 21.55% -32.72% -263.94% -156.34% -303.07% -299.36% -379.56% -82.88% -299.73% 
      interest expense
    -45,406,000 -48,576,000 -47,363,000 -53,706,000 -51,256,000 -58,702,000 -62,023,000 -66,116,000 -70,324,000 -71,497,000 -73,470,000 -74,147,000 -74,125,000 -80,244,000 -63,189,000 -70,684,000 -88,598,000 -93,372,000 -69,420,000 -27,376,000 -27,573,000 -27,428,000 -26,210,000 -18,496,000 -18,244,000 -17,861,000 -18,234,000 -17,922,000 -17,904,000 -18,920,000 -19,646,000 -20,605,000 -21,426,000 -19,192,000 -18,294,000 -18,844,000 -19,131,000 -18,498,000 -12,121,000 -12,192,000 -12,210,000 -12,650,000 -15,812,000 -16,245,000 -16,678,000 -14,530,000 -11,429,000 -10,076,000 -6,173,000 -6,202,000 -7,142,000  -7,670,000 -7,750,000 -1,481,000 -58,000 -110,000 -129,000 -659,000 -777,000 -1,077,000 -1,197,000 -4,687,000 -5,767,000 -5,762,000 -5,384,000 -5,856,000 -5,794,000 -5,365,000 -5,355,000 -5,235,000 -3,787,000 -3,554,000 -3,511,000 -3,314,000 
      foreign exchange gain
    -658,000 102,000 -1,799,000    507,000 -1,693,000   -2,382,000 3,193,000 -4,133,000 -4,649,000 -1,343,000 -10,540,000 315,500 -2,631,000 2,950,000 943,000                                                        
      income before income tax benefit and equity in loss of investees
    208,471,000 9,035,000 -735,554,000  133,219,000 200,807,000 137,927,000  59,100,750 99,518,000 81,784,000                                                                 
      income tax benefit
    4,963,000 -242,424,000 -17,170,000  -57,912,000 -14,533,000 -30,653,000  -21,705,750 -47,176,000 -24,323,000                                                                 
      equity in loss of investees
    57,000 47,000 86,000 542,000 16,000 285,000 12,000 1,347,000 461,000 -126,000 1,669,000 1,005,000 773,000 2,545,000 2,461,000 4,142,000 2,988,000 3,256,000 -1,365,000  624,000 623,000 1,897,000 -182,000 1,298,000 1,030,000 868,000 893,000 843,000 437,000 586,000 337,000 372,000 273,000                                          
      net income
    203,451,000 251,412,000 -718,470,000 -92,541,000 191,115,000 215,055,000 168,568,000 -14,618,000 94,154,000 146,820,000 104,438,000 69,420,000 -240,724,000 -19,648,000 34,665,000 1,647,000 -35,351,000 -52,833,000 -363,316,000 121,832,000 133,414,000 148,234,000 114,801,000 -157,833,000 73,992,000 102,276,000 261,898,000 85,201,000 159,470,000 149,316,000 92,321,000 45,991,000 232,207,000 63,526,000 105,604,000 86,511,000 124,283,000 87,145,000 111,282,000 74,121,000 82,761,000 87,960,000 88,113,000 70,700,000 81,611,000 25,768,000 43,586,000 -93,639,000 55,293,000 75,409,000 42,185,000 43,425,000 200,551,000 33,209,000 27,145,000 27,681,000 37,473,000 32,482,000 33,202,000 21,827,000 24,459,000 13,243,000 -6,388,000 1,464,000 5,653,000 -1,672,000 2,171,000 -12,988,000 -56,940,000 -28,809,000 -51,880,000 -46,710,000 -60,020,000 -19,359,000 -39,863,000 
      yoy
    6.45% 16.91% -526.22% 533.06% 102.98% 46.48% 61.40% -121.06% -139.11% -847.25% 201.28% 4114.94% 580.95% -62.81% -109.54% -98.65% -126.50% -135.64% -416.47% -177.19% 80.31% 44.94% -56.17% -285.25% -53.60% -31.50% 183.68% 85.26% -31.32% 135.05% -12.58% -46.84% 86.84% -27.10% -5.10% 16.72% 50.17% -0.93% 26.29% 4.84% 1.41% 241.35% 102.16% -175.50% 47.60% -65.83% 3.32% -315.63% -72.43% 127.07% 55.41% 56.88% 435.19% 2.24% -18.24% 26.82% 53.21% 145.28% -619.76% 1390.92% 332.67% -892.05% -394.24% -111.27% -109.93% -94.20% -104.18% -72.19% -5.13% 48.81% 30.15%     
      qoq
    -19.08% -134.99% 676.38% -148.42% -11.13% 27.58% -1253.15% -115.53% -35.87% 40.58% 50.44% -128.84% 1125.18% -156.68% 2004.74% -104.66% -33.09% -85.46% -398.21% -8.68% -10.00% 29.12% -172.74% -313.31% -27.65% -60.95% 207.39% -46.57% 6.80% 61.74% 100.74% -80.19% 265.53% -39.85% 22.07% -30.39% 42.62% -21.69% 50.14% -10.44% -5.91% -0.17% 24.63% -13.37% 216.71% -40.88% -146.55% -269.35% -26.68% 78.76% -2.86% -78.35% 503.91% 22.34% -1.94% -26.13% 15.37% -2.17% 52.11% -10.76% 84.69% -307.31% -536.34% -74.10% -438.10% -177.02% -116.72% -77.19% 97.65% -44.47% 11.07% -22.18% 210.04% -51.44%  
      net income margin %
    16.98% 22.33% -68.71% -10.31% 17.56% 20.38% 16.46% -1.62% 9.30% 15.10% 10.91% 7.78% -24.76% -2.09% 3.72% 0.20% -3.94% -6.30% -48.33% 20.05% 20.05% 24.67% 20.41% -29.52% 12.72% 19.02% 49.03% 16.77% 33.47% 31.81% 18.45% 10.34% 53.21% 15.42% 26.78% 23.01% 31.34% 23.29% 29.20% 22.06% 24.28% 25.80% 26.40% 22.86% 24.87% 8.40% 14.97% -37.92% 23.45% 32.48% 20.26% 22.13% 109.17% 18.92% 20.96% 25.53% 44.86% 44.32% 51.42% 42.90% 45.83% 29.59% -15.78% 4.16% 14.77% -5.43% 5.82% -58.83% -290.58% -162.34% -333.87% -319.19% -387.80% -90.15% -279.47% 
      net income per ordinary share:
                                                                               
      basic
    3,340 4,140 -11,740  3,130 3,500 2,680 -230 1,500 2,330 1,630 1,090 -3,850 -310 560 30 -540 -860 -6,110 2,160 2,390 2,670 2,070 -2,820 1,975 1,800 4,620 1,490 1,195 2,470 1,530 770 1,065 1,060 1,760 1,440    1,210     -97.5 430 730 -1,580       480 510 0.89 0.77 0.81 0.54 0.66 0.34 -0.18 0.05   0.07         
      diluted
    3,340 4,080 -11,740  3,020 3,420 2,490 -230 1,430 2,140 1,520 1,040 -3,840 -310 550 30 -540 -860 -6,110 2,090 2,350 2,640 2,060 -2,820 1,950 1,780 4,560 1,470 1,170 2,410 1,500 750 1,042.5 1,030 1,720 1,410    1,190     -97.5 410 700 -1,580       450 480 0.79 0.69 0.71 0.48 0.61 0.32 -0.18 0.04   0.07         
      weighted-average ordinary shares used in per share calculations - basic
    60,981 60,696 61,194  61,838 61,414 62,882 62,537 63,291 63,114 63,991 63,494 62,539 62,785 62,436 61,865 59,694 61,284 59,448 56,468 55,712 55,545 55,413 55,956 56,749 56,674 56,707 57,206 59,976 60,476 60,177 59,928 60,018 60,108 60,100 59,880 60,500 60,437 60,499 61,142                                    
      weighted-average ordinary shares used in per share calculations - diluted
    60,981 61,606 61,194  66,007 63,174 69,625 62,537 72,066 71,293 73,540 73,771 62,539 62,785 63,431 62,907 59,694 61,284 59,448 58,393 56,517 56,236 55,864 55,956 57,550 57,438 57,427 58,081 61,221 61,857 61,438 61,178 61,317 61,436 61,463 61,178 61,870 61,644 61,833 62,474                                    
      foreign exchange loss
       -213,000 -471,750 -701,000   -141,500 -1,377,000           -558,750 -639,000 -464,000 -1,132,000 -894,250 -1,033,000 -1,933,000 -611,000 -1,295,250 -756,000 -2,697,000 -1,728,000 -2,278,750 -2,224,000 -5,427,000 -1,464,000                                        
      income before income tax (benefit) expense and equity in loss of investees
       -109,811,000                                                                        
      income tax (benefit) expense
       -17,812,000                                                                        
      net income per ordinary share:
                                                                               
      basic and diluted
       -1,520                                                             -0.105 -0.05          
      weighted-average ordinary shares used in per share calculations - basic and diluted
       60,979                                                                        
      income before income tax expense and equity in loss of investees
           -1,602,000    55,101,000   21,014,000 6,325,000                                                            
      income tax expense
           11,669,000    -15,324,000 -100,042,000 -43,027,000 -16,112,000 536,000                                                            
      impairment charge
                 133,648,000       34,034,750   136,139,000                                                    
      loss before income tax expense and equity in loss of investees
                -8,197,750 -60,130,000                                                              
      income before income tax provision and equity in loss of investees
                    -17,002,000 -67,634,000 -136,060,000  144,805,000 168,140,000 171,452,000 -209,302,000 40,767,000 114,209,000 184,116,000 115,210,000 165,457,000 169,101,000 129,431,000 65,474,000 118,925,000 65,038,000                                          
      income tax provision
                    57,145,750 -18,057,000 228,621,000 18,019,000 10,767,000 19,283,000 54,754,000 -51,287,000 -34,523,000 10,903,000 -78,650,000 29,116,000 5,144,000 19,348,000 36,524,000 19,146,000 -113,654,000 1,239,000 35,515,000 29,160,000 26,754,000 29,120,000 45,332,000 34,030,000 13,748,000 29,945,000 30,647,000 32,059,000 33,633,000 24,221,000 19,350,000 17,027,000 32,064,000 18,335,000 23,605,000 17,634,000                        
      income before income tax provision and equity in gain of investees
                       135,686,000                                                        
      equity in gain of investees
                       -4,165,000                                                        
      impairment charges
                                  42,896,000                                             
      loss on extinguishment and modification of debt
                                  -1,425,000       -638,000     -16,815,000        -3,749,000                         
      income before income tax provision and equity in loss of investee
                                      141,322,000 115,832,000                                        
      equity in loss of investee
                                      203,000 161,000                                        
      foreign currency loss
                                        -392,000 -749,000           -969,000 -614,000 -385,000                         
      income before income tax provision and equity in loss of investee, net of tax
                                        95,283,250 116,368,000                                      
      equity in loss of investee, net of tax
                                        25,750 103,000                                      
      net loss attributable to noncontrolling interests, net of tax
                                              -1,000    -73,000 -989,000                            
      net income attributable to jazz pharmaceuticals plc
                                        124,283,000 87,145,000 111,282,000  82,761,000 87,960,000 88,114,000 70,700,000 81,612,000 25,766,000 43,659,000 -92,650,000                            
      net income attributable to jazz pharmaceuticals plc per ordinary share:
                                                                               
      basic
                                        1,122.5 1,440 1,840  1,010 1,430 1,440 1,160                                
      diluted
                                        1,100 1,410 1,800  977.5 1,390 1,400 1,120                                
      foreign currency gain
                                           -819,000 2,091,000 -977,000 -1,914,000 2,245,000 2,003,000 6,483,000 74,000 123,000    271,000                        
      income before income tax provision
                                          156,614,000 108,151,000 84,856,000 117,905,000 118,760,000 102,759,000 9,078,250 49,989,000 62,936,000 -76,612,000                            
      net income attributable to noncontrolling interests, net of tax
                                            -250    -265,000 2,000                              
      weighted-average ordinary shares used in per share calculation - basic
                                            61,232 61,435                                  
      weighted-average ordinary shares used in per share calculation - diluted
                                            63,036 63,154                                  
      weighted-average ordinary shares used in calculating net income attributable to jazz pharmaceuticals plc per ordinary share:
                                                                               
      basic
                                              61,190,000 60,803,000 59,746,000 60,305,000 59,519,000 58,526,000 58,298,000 58,217 58,737 58,358 56,643,000 57,703 56,952 53,923 41,499 42,028 41,209 40,362 36,343 38,965 35,423 31,412   29,021         
      diluted
                                              63,090,000 62,964,000 62,614,000 62,680,000 62,378,000 58,526,000 61,569,000 61,519 61,568 61,511 60,195,000 60,883 60,554 58,084 46,798 47,241 46,601 45,697 39,411 41,737 35,423 34,926   29,023         
      intangible asset impairment
                                                8,201,500  32,806,000                             
      net income per ordinary share attributable to jazz pharmaceuticals plc:
                                                                               
      basic
    3,340 4,140 -11,740  3,130 3,500 2,680 -230 1,500 2,330 1,630 1,090 -3,850 -310 560 30 -540 -860 -6,110 2,160 2,390 2,670 2,070 -2,820 1,975 1,800 4,620 1,490 1,195 2,470 1,530 770 1,065 1,060 1,760 1,440    1,210     -97.5 430 730 -1,580       480 510 0.89 0.77 0.81 0.54 0.66 0.34 -0.18 0.05   0.07         
      diluted
    3,340 4,080 -11,740  3,020 3,420 2,490 -230 1,430 2,140 1,520 1,040 -3,840 -310 550 30 -540 -860 -6,110 2,090 2,350 2,640 2,060 -2,820 1,950 1,780 4,560 1,470 1,170 2,410 1,500 750 1,042.5 1,030 1,720 1,410    1,190     -97.5 410 700 -1,580       450 480 0.79 0.69 0.71 0.48 0.61 0.32 -0.18 0.04   0.07         
      weighted-average ordinary shares used in calculating net income per ordinary share attributable to jazz pharmaceuticals plc:
                                                                               
      basic
                                              61,190,000 60,803,000 59,746,000 60,305,000 59,519,000 58,526,000 58,298,000 58,217 58,737 58,358 56,643,000 57,703 56,952 53,923 41,499 42,028 41,209 40,362 36,343 38,965 35,423 31,412   29,021         
      diluted
                                              63,090,000 62,964,000 62,614,000 62,680,000 62,378,000 58,526,000 61,569,000 61,519 61,568 61,511 60,195,000 60,883 60,554 58,084 46,798 47,241 46,601 45,697 39,411 41,737 35,423 34,926   29,023         
      income from continuing operations before income tax provision
                                                    87,357,000 93,744,000 65,790,000 61,059,000                        
      income from continuing operations
                                                    55,293,000 75,409,000 42,185,000 43,425,000 166,206,000 33,595,000                      
      loss from discontinued operations
                                                        -1,727,000 -386,000                      
      basic income per ordinary share:
                                                                               
      diluted income per ordinary share:
                                                                               
      weighted-average ordinary shares used in per share computations:
                                                                               
      basic
                                              61,190,000 60,803,000 59,746,000 60,305,000 59,519,000 58,526,000 58,298,000 58,217 58,737 58,358 56,643,000 57,703 56,952 53,923 41,499 42,028 41,209 40,362 36,343 38,965 35,423 31,412   29,021         
      diluted
                                              63,090,000 62,964,000 62,614,000 62,680,000 62,378,000 58,526,000 61,569,000 61,519 61,568 61,511 60,195,000 60,883 60,554 58,084 46,798 47,241 46,601 45,697 39,411 41,737 35,423 34,926   29,023         
      interest income
                                                       -7,399,000        1,000 1,000 1,000 2,000 2,000 5,000 2,000 6,000 21,000 134,000 353,000 450,000 897,000 1,582,000 1,969,000 1,300,000 
      foreign exchange and other
                                                        -339,250 -1,099,000                      
      loss on extinguishment of debt
                                                            -150,000 -1,097,000     -12,287,000             
      income from continuing operations before provision for income tax expense
                                                        29,977,250 46,451,000                      
      provision for income tax expense
                                                        6,241,500 12,856,000 6,593,000 5,517,000                    
      other expense
                                                          -240,000     -1,000       -13,000     -12,000    
      income before provision for income tax expense
                                                          33,738,000 33,198,000                    
      weighted-average ordinary shares used in computing net income per share:
                                                                               
      basic
                                              61,190,000 60,803,000 59,746,000 60,305,000 59,519,000 58,526,000 58,298,000 58,217 58,737 58,358 56,643,000 57,703 56,952 53,923 41,499 42,028 41,209 40,362 36,343 38,965 35,423 31,412   29,021         
      diluted
                                              63,090,000 62,964,000 62,614,000 62,680,000 62,378,000 58,526,000 61,569,000 61,519 61,568 61,511 60,195,000 60,883 60,554 58,084 46,798 47,241 46,601 45,697 39,411 41,737 35,423 34,926   29,023         
      interest income and other
                                                           71,000 69,000 4,000 2,000                 
      royalties
                                                            576,000 792,000 819,000 693,000 728,000 630,000 674,000 605,000 681,000 532,000 518,000 472,000 431,000 440,000 503,000 365,000 332,000 253,000 360,000 
      contract revenues
                                                            213,500 285,000 284,000 285,000 284,000 285,000 284,000 285,000 284,000 285,000 10,284,000 285,000 284,000 284,000 285,000 285,000    
      net income per share
                                                                       -0.45 -1.28 -1.07 -2.17 -1.97    
      basic
    3,340 4,140 -11,740  3,130 3,500 2,680 -230 1,500 2,330 1,630 1,090 -3,850 -310 560 30 -540 -860 -6,110 2,160 2,390 2,670 2,070 -2,820 1,975 1,800 4,620 1,490 1,195 2,470 1,530 770 1,065 1,060 1,760 1,440    1,210     -97.5 430 730 -1,580       480 510 0.89 0.77 0.81 0.54 0.66 0.34 -0.18 0.05   0.07         
      diluted
    3,340 4,080 -11,740  3,020 3,420 2,490 -230 1,430 2,140 1,520 1,040 -3,840 -310 550 30 -540 -860 -6,110 2,090 2,350 2,640 2,060 -2,820 1,950 1,780 4,560 1,470 1,170 2,410 1,500 750 1,042.5 1,030 1,720 1,410    1,190     -97.5 410 700 -1,580       450 480 0.79 0.69 0.71 0.48 0.61 0.32 -0.18 0.04   0.07         
      weighted-average common shares used in computing net income per share:
                                                                               
      basic
                                              61,190,000 60,803,000 59,746,000 60,305,000 59,519,000 58,526,000 58,298,000 58,217 58,737 58,358 56,643,000 57,703 56,952 53,923 41,499 42,028 41,209 40,362 36,343 38,965 35,423 31,412   29,021         
      diluted
                                              63,090,000 62,964,000 62,614,000 62,680,000 62,378,000 58,526,000 61,569,000 61,519 61,568 61,511 60,195,000 60,883 60,554 58,084 46,798 47,241 46,601 45,697 39,411 41,737 35,423 34,926   29,023         
      other income
                                                                 -4,000 2,000   1,000  8,000 10,000 19,000 -1,000  -19,000 -19,000 4,904,000 
      amortization of intangible assets
                                                                    1,402,750 2,057,000 1,822,000 1,732,000 2,363,500 3,487,000 3,846,000 2,121,000 1,734,000 2,287,000 2,287,000 
      gain on sale of product rights
                                                                         3,918,000   715,000   
      net income per share
                                                                       -0.45 -1.28 -1.07 -2.17 -1.97    
      basic and diluted
       -1,520                                                             -0.105 -0.05          
      weighted-average common shares used in computing net loss per share:
                                                                               
      basic and diluted
                                                                     30,895          
      net income per share
                                                                       -0.45 -1.28 -1.07 -2.17 -1.97    
      weighted-average common shares used in computing net loss per share, basic and diluted
                                                                    30,018   28,925  26,994 23,858 23,743    
      provision for government settlement
                                                                              17,469,000 
      contract revenue
                                                                            2,581,500 7,785,000 289,000 
      gain on extinguishment of development financing obligation
                                                                               
      beneficial conversion feature
                                                                               
      income attributable to common stockholders
                                                                            -19,701,500 -19,359,000  
      income per share attributable to common stockholders, basic
                                                                            -1.875 -0.82  
      weighted-average common shares used in computing income per share attributable to common stockholders, basic
                                                                             23,671  
      income per share attributable to common stockholders, diluted
                                                                            -1.875 -0.82  
      shares used in computing income per share attributable to common stockholders, diluted
                                                                            2,626.25 23,671  
      loss attributable to common stockholders
                                                                              -39,863,000 
      loss per share attributable to common stockholders, basic and diluted
                                                                              -5.27 
      weighted-average common shares used in computing loss per share attributable to common stockholders, basic and diluted
                                                                        25,646    13,829  7,561 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 
                                                                                 
        assets
                                                                                 
        current assets:
                                                                                 
        cash and cash equivalents
      1,391,899,000 1,326,070,000 1,189,880,000 1,861,946,000 2,412,864,000 2,218,135,000 1,355,802,000 1,443,385,000 1,506,310,000 1,335,690,000 1,282,304,000 1,167,911,000 881,482,000 839,358,000 711,265,000 490,835,000 591,448,000 671,780,000 891,400,000 2,097,533,000 1,057,769,000 741,942,000 786,082,000 701,602,000 637,344,000 795,175,000 637,739,000 547,466,000 309,622,000 499,018,000 485,081,000 453,169,000 386,035,000 252,615,000 239,213,000 346,995,000 365,963,000 366,567,000 867,966,000 979,780,000 988,785,000 998,859,000 921,643,000 782,603,000 684,042,000 575,040,000 268,255,000 245,874,000 636,504,000 588,462,000 504,307,000 450,511,000 387,196,000 189,793,000 154,543,000 170,654,000 82,076,000 101,215,000 102,396,000 65,061,000 44,794,000 22,853,000 9,574,000 18,998,000 15,595,000 12,230,000 15,772,000 17,015,000 24,903,000 49,907,000 51,202,000 100,771,000 102,945,000 119,972,000 148,000,000 
        investments
      1,050,000,000 720,000,000 480,000,000 710,000,000 580,000,000 400,000,000 625,000,000 375,000,000 120,000,000 250,000,000 80,000,000   60,000,000 60,000,000     335,000,000 1,075,000,000 1,175,000,000 910,000,000 280,000,000 440,000,000 275,000,000 245,000,000 285,000,000 515,000,000 565,000,000 330,000,000 255,000,000 215,000,000 200,000,000 80,000,000 60,000,000 60,000,000 59,418,000 48,409,000 764,000        5,502,000                            
        accounts receivable
      830,747,000 764,364,000 714,004,000 652,992,000 716,765,000 723,639,000 698,037,000 707,095,000 705,794,000 627,841,000 610,389,000 623,938,000 651,493,000 601,179,000 594,034,000 572,392,000 563,360,000 499,023,000 506,660,000 413,976,000 396,490,000 361,664,000 351,920,000 317,301,000 355,987,000 267,031,000 311,249,000 320,485,000 263,838,000 279,437,000 278,441,000 281,424,000 224,129,000 258,616,000 238,752,000 243,035,000 234,244,000 238,072,000 231,837,000 223,802,000 209,685,000 195,816,000 193,647,000 189,682,000 186,371,000 187,604,000 160,775,000 154,986,000 124,805,000 113,271,000 114,075,000 93,833,000 75,480,000 88,304,000 78,130,000 56,143,000 34,374,000 31,428,000 24,999,000 21,383,000 22,081,000 14,114,000 14,095,000 11,955,000 12,313,000 9,202,000 9,197,000 7,012,000 6,643,000 6,686,000 5,221,000 5,310,000 5,389,000 6,566,000 6,462,000 
        inventories
      416,962,000 483,111,000 504,989,000 492,776,000 480,445,000 539,302,000 542,555,000 577,321,000 597,039,000 611,827,000 657,214,000 674,778,000 714,061,000 728,074,000 861,705,000 985,454,000 1,072,721,000 1,137,851,000 1,251,259,000 115,475,000 95,396,000 91,404,000 92,534,000 85,610,000 78,608,000 71,108,000 68,999,000 60,707,000 52,956,000 43,435,000 46,156,000 46,384,000 43,245,000 41,344,000 39,658,000 37,653,000 34,051,000 32,351,000 33,291,000 25,369,000 19,451,000 30,018,000 30,781,000 30,692,000 30,037,000 37,612,000 33,098,000 36,988,000 28,669,000 24,868,000 28,130,000 22,830,000 26,525,000 30,300,000 48,355,000 16,992,000 3,909,000 4,297,000 4,736,000 5,017,000 5,046,000 4,476,000 4,429,000 3,522,000 3,426,000 4,532,000 4,193,000 4,430,000 4,788,000 6,264,000 6,219,000 2,200,000 2,213,000 3,231,000 3,216,000 
        prepaid expenses
      152,481,000 146,892,000 164,000,000 150,280,000 177,411,000 155,132,000 134,421,000 122,562,000 185,476,000 109,990,000 107,490,000 72,779,000 91,912,000 92,877,000 108,304,000 117,399,000 131,413,000 94,474,000 104,455,000 57,185,000 62,422,000 58,305,000 49,109,000 38,824,000 39,434,000 30,841,000 31,712,000 28,974,000 25,017,000 23,189,000 33,586,000 27,476,000 23,182,000 29,249,000 28,433,000 38,118,000 24,501,000 23,304,000 23,143,000 18,472,000 20,699,000 21,275,000 26,250,000 27,614,000 12,800,000 24,206,000 28,447,000 14,335,000 7,183,000 19,350,000 21,410,000 11,286,000 7,445,000 7,127,000 5,906,000 5,714,000 1,690,000 2,535,000 3,575,000 2,577,000 1,858,000 1,992,000 2,287,000 2,324,000 1,653,000 1,969,000 2,426,000 2,206,000 2,366,000 3,114,000 3,680,000 3,210,000 3,224,000 2,392,000 2,655,000 
        other current assets
      323,954,000 315,441,000 297,560,000 259,823,000 261,543,000 354,215,000 325,851,000 314,535,000 320,809,000 310,404,000 272,458,000 245,244,000 267,192,000 250,016,000 255,525,000 243,888,000 252,392,000 225,098,000 200,190,000 147,727,000 152,491,000 127,258,000 112,701,000 94,300,000 78,895,000 81,401,000 75,367,000 62,985,000 67,572,000 54,310,000 55,634,000 62,868,000 76,686,000 49,120,000 36,448,000 27,052,000 29,310,000 24,517,000 26,244,000 22,431,000 19,047,000 18,969,000 21,985,000 21,522,000 21,322,000 18,362,000 18,468,000 23,747,000 33,843,000 18,551,000 19,716,000 21,395,000 19,113,000 9,942,000 13,508,000 4,073,000 1,260,000 532,000 382,000 402,000 279,000 962,000 788,000 992,000 979,000 261,000 62,000 2,106,000 2,382,000 736,000 376,000 1,346,000 381,000 1,574,000 547,000 
        total current assets
      4,166,043,000 3,755,878,000 3,350,433,000 4,127,817,000 4,629,028,000 4,390,423,000 3,681,666,000 3,539,898,000 3,435,428,000 3,245,752,000 3,009,855,000 2,784,650,000 2,606,140,000 2,571,504,000 2,590,833,000 2,500,856,000 2,611,334,000 2,628,226,000 2,953,964,000 3,166,896,000 2,839,568,000 2,555,573,000 2,302,346,000 1,517,637,000 1,630,268,000 1,520,556,000 1,370,066,000 1,305,617,000 1,234,005,000 1,464,389,000 1,306,931,000 1,126,321,000 968,277,000 830,944,000 662,504,000 752,853,000 748,069,000 744,229,000 1,230,890,000 1,270,618,000 1,257,667,000 1,314,943,000 1,244,910,000 1,102,935,000 1,015,845,000 878,520,000 544,912,000 517,320,000 864,617,000 810,067,000 734,176,000 647,372,000 551,572,000 385,012,000 300,442,000 327,140,000 199,131,000 152,140,000 136,088,000 94,840,000 74,458,000 44,797,000 32,083,000 38,742,000 36,954,000 29,144,000 32,725,000 33,544,000 43,999,000 69,704,000 70,196,000 119,245,000 116,091,000 144,978,000 161,155,000 
        property, plant and equipment
      199,857,000 188,913,000 184,975,000 178,869,000 173,413,000 176,422,000 169,281,000 166,236,000 169,646,000 222,476,000 229,264,000 227,552,000 228,050,000 216,339,000 239,523,000 257,632,000 256,837,000 255,006,000 277,066,000 123,863,000 127,935,000 128,204,000 128,259,000 129,562,000 131,506,000 129,472,000 127,183,000 113,006,000 200,358,000 198,053,000 188,086,000 178,920,000                                            
        operating lease assets
      58,880,000 61,204,000 63,082,000 49,181,000 53,582,000 77,164,000 73,145,000 61,637,000 65,340,000 65,038,000 69,040,000 75,538,000 73,326,000 73,728,000 78,365,000 83,412,000 86,586,000 89,628,000 149,254,000 125,738,000 129,169,000 130,717,000 133,179,000 135,976,000 139,385,000 141,878,000 144,746,000 147,365,000                                                
        intangible assets
      4,429,510,000 4,565,737,000 4,768,987,000 4,718,158,000 4,755,695,000 5,144,217,000 5,079,462,000 5,235,496,000 5,418,039,000 5,417,860,000 5,705,777,000 5,764,209,000 5,794,437,000 5,570,394,000 6,237,959,000 6,783,057,000 7,152,328,000 7,282,579,000 7,588,029,000 2,108,046,000 2,195,051,000 2,241,107,000 2,286,126,000 2,238,658,000 2,440,977,000 2,593,030,000 2,687,941,000 2,679,393,000 2,731,334,000 2,787,281,000 2,842,277,000 2,953,146,000 2,979,127,000 3,019,035,000 3,033,103,000 2,998,780,000 3,012,001,000 3,110,439,000 1,300,761,000 1,348,160,000 1,185,606,000 1,270,777,000 1,282,955,000 1,284,308,000 1,437,435,000 1,550,624,000 1,680,004,000 1,755,861,000 812,396,000 823,724,000 822,976,000 835,003,000 869,952,000 876,959,000 927,409,000 326,072,000 14,585,000 16,447,000 18,309,000 20,171,000 22,033,000 23,895,000 25,757,000 27,802,000 29,858,000 31,915,000 33,972,000 35,794,000 32,526,000 65,663,000 71,074,000 74,919,000 36,040,000 58,664,000 60,952,000 
        goodwill
      1,829,340,000 1,827,483,000 1,843,974,000 1,760,045,000 1,716,323,000 1,804,646,000 1,735,931,000 1,739,495,000 1,753,130,000 1,705,320,000 1,742,675,000 1,723,444,000 1,692,662,000 1,592,635,000 1,687,648,000 1,782,444,000 1,827,609,000 1,849,547,000 1,887,699,000 938,398,000 958,303,000 937,099,000 918,021,000 909,226,000 920,018,000 906,725,000 924,990,000 919,972,000 927,630,000 932,422,000 936,493,000 960,509,000 947,537,000 941,428,000 926,290,000 899,290,000 893,810,000 927,993,000 661,845,000 670,991,000 657,139,000 669,029,000 664,015,000 654,470,000 702,713,000 724,388,000 760,314,000 763,763,000 450,456,000 446,823,000 439,014,000 436,355,000 442,600,000 437,652,000 446,236,000 239,737,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 
        deferred tax assets
      869,130,000 846,168,000 602,903,000 575,097,000 560,245,000 583,218,000 545,222,000 507,749,000 477,834,000 464,367,000 430,086,000 399,097,000 376,247,000 314,965,000 320,550,000 314,672,000 311,103,000 314,666,000 296,493,000 258,454,000 254,916,000 254,810,000 243,395,000 230,242,000 221,403,000 183,944,000 184,383,000 65,090,000 57,879,000 37,582,000 40,997,000 38,103,000 34,559,000         50,006,000 50,604,000 50,822,000 48,440,000 35,696,000 35,869,000 35,888,000 33,613,000 45,565,000 46,538,000 47,517,000 35,813,000                       
        deferred financing costs
      7,550,000 8,034,000 8,516,000 8,999,000 9,489,000 4,395,000 5,736,000 5,784,000 6,478,000 7,172,000 7,865,000 8,559,000 9,254,000 9,949,000 10,643,000 11,336,000 12,029,000 12,724,000 13,406,000 4,724,000 5,238,000 5,802,000 6,347,000 6,887,000 7,426,000 7,971,000 8,517,000 9,056,000 9,589,000 10,058,000 10,779,000 7,144,000 7,673,000 8,149,000 8,705,000 9,325,000 9,737,000 10,258,000 6,610,000 6,843,000 23,268,000 24,315,000 25,188,000 31,223,000 33,174,000 35,068,000 24,427,000 25,896,000 14,605,000 15,458,000 16,308,000 15,686,000 16,576,000                       
        other non-current assets
      99,030,000 103,068,000 121,271,000 116,516,000 114,482,000 75,231,000 71,425,000 70,780,000 67,464,000 76,080,000 65,978,000 64,076,000 55,139,000 35,153,000 34,612,000 35,508,000 40,813,000 45,776,000 47,082,000 30,351,000 25,721,000 38,646,000 48,828,000 47,107,000 47,914,000 44,274,000 40,835,000 40,736,000 42,696,000 56,003,000 23,404,000 22,985,000 16,419,000 16,420,000 16,638,000 17,625,000 14,060,000 37,764,000 37,005,000 29,543,000 27,548,000 25,393,000 22,498,000 19,189,000 15,931,000 13,482,000 11,135,000 9,296,000 7,304,000 6,391,000 5,502,000                         
        total assets
      11,659,340,000 11,356,485,000 10,944,141,000 11,534,682,000 12,012,257,000 12,255,716,000 11,361,868,000 11,327,075,000 11,393,359,000 11,204,065,000 11,260,540,000 11,047,125,000 10,835,255,000 10,384,667,000 11,200,133,000 11,768,917,000 12,298,639,000 12,478,152,000 13,212,993,000 6,756,470,000 6,535,901,000 6,291,958,000 6,066,501,000 5,215,295,000 5,538,897,000 5,527,850,000 5,488,661,000 5,280,235,000 5,203,491,000 5,485,788,000 5,348,967,000 5,287,128,000 5,123,672,000 4,999,024,000 4,804,024,000 4,815,824,000 4,800,227,000 4,930,581,000 3,448,094,000 3,534,979,000 3,359,663,000 3,464,300,000 3,393,274,000 3,237,593,000 3,338,955,000 3,347,536,000 3,155,749,000 3,196,434,000 2,238,221,000 2,185,499,000 2,093,880,000 2,009,690,000 1,966,493,000 1,726,699,000 1,697,944,000 895,360,000 253,573,000 207,813,000 193,409,000 154,178,000 135,729,000 107,992,000 97,264,000 106,706,000 107,396,000 102,172,000 108,574,000 109,937,000 117,498,000 179,793,000 186,591,000 239,018,000 207,554,000 258,767,000 276,870,000 
        liabilities and shareholders’ equity
                                                                                 
        current liabilities:
                                                                                 
        accounts payable
      122,061,000 152,227,000 89,366,000 95,930,000 77,869,000 85,425,000 97,096,000 80,976,000 102,750,000 109,850,000 98,428,000 125,454,000 90,758,000 102,249,000 74,161,000 73,336,000 100,298,000 63,815,000 64,826,000 77,738,000 26,945,000 67,063,000 50,043,000 66,308,000 47,545,000 70,104,000 82,222,000 42,669,000 40,602,000 37,373,000 31,379,000 46,933,000 24,368,000 29,972,000 28,529,000 29,144,000 22,415,000 17,626,000 28,406,000 32,622,000 21,807,000 29,124,000 26,409,000 27,317,000 25,126,000 29,671,000 32,555,000 72,538,000 21,005,000 22,434,000 20,367,000 31,634,000 15,887,000 20,535,000 34,505,000 13,689,000 5,129,000 8,463,000 4,665,000 3,648,000 3,049,000 3,891,000 6,403,000 3,885,000 2,158,000 5,240,000 4,074,000 4,554,000 5,736,000 6,614,000 8,522,000 8,915,000 2,856,000 2,872,000 4,268,000 
        accrued liabilities
      1,034,170,000 1,001,556,000 874,811,000 1,063,918,000 910,947,000 858,578,000 800,993,000 826,530,000 793,914,000 769,942,000 748,304,000 712,349,000 803,255,000 668,390,000 593,207,000 604,710,000 666,304,000 603,715,000 561,091,000 374,035,000 352,732,000 302,071,000 266,918,000 261,041,000 267,873,000 238,740,000 218,751,000 292,390,000 264,887,000 257,453,000 258,794,000 240,544,000 198,779,000 179,890,000 169,701,000 183,645,000 193,268,000 172,418,000 157,622,000 307,504,000 164,070,000 166,375,000 146,053,000 146,975,000 164,091,000 161,476,000 142,843,000 147,737,000 119,718,000 106,390,000 96,771,000 100,935,000 104,666,000 123,632,000 125,080,000 74,566,000 34,783,000 35,834,000 26,713,000 23,274,000 23,572,000 19,075,000 16,217,000 15,368,000 14,296,000 21,370,000 22,147,000 21,401,000 19,024,000 23,161,000 31,252,000 30,133,000 29,047,000 23,892,000 22,198,000 
        current portion of long-term debt
      1,029,903,000 1,029,179,000 1,028,478,000 31,000,000 31,000,000 31,000,000 605,798,000 605,375,000 604,954,000 604,507,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 248,585,000 248,613,000 246,322,000 243,999,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 45,117,000 40,605,000 36,094,000 36,094,000 136,094,000 36,094,000 36,094,000 37,500,000 37,592,000 37,587,000 117,589,000 28,478,000 9,388,000 9,428,000 9,444,000 9,473,000 9,513,000 5,572,000 5,572,000 5,572,000 32,656,000 29,688,000 26,719,000 23,750,000    32,693,000 16,131,000 16,064,000 15,995,000 15,925,000             
        income taxes payable
      56,387,000 91,140,000 78,550,000 31,762,000 18,757,000 54,974,000 52,138,000 49,325,000 35,074,000 89,026,000 67,529,000 40,095,000 7,717,000 10,444,000 5,796,000 26,677,000 9,608,000 34,256,000 3,645,000 49,334,000 25,200,000 25,910,000 55,979,000 31,211,000 10,965,000 43,488,000 30,413,000 40,833,000 1,197,000 7,139,000 17,934,000 36,048,000 21,577,000 13,603,000 7,494,000 35,300,000 4,506,000 5,222,000 1,761,000 19,735,000 1,808,000 16,357,000 13,456,000 26,334,000 7,588,000 15,755,000 5,500,000 824,000 336,000 19,850,000 17,539,000 37,803,000 39,884,000                       
        total current liabilities
      2,242,521,000 2,274,102,000 2,071,205,000 1,222,610,000 1,038,573,000 1,029,977,000 1,556,025,000 1,562,206,000 1,536,692,000 1,573,329,000 945,265,000 908,902,000 933,193,000 812,954,000 705,442,000 737,409,000 809,303,000 735,053,000 880,588,000 752,093,000 653,745,000 642,133,000 409,960,000 396,123,000 364,490,000 390,439,000 369,493,000 413,999,000 345,487,000 341,287,000 347,950,000 375,619,000 293,947,000 268,177,000 250,393,000 392,773,000 257,406,000 232,859,000 226,721,000 398,831,000 226,642,000 340,192,000 225,164,000 220,582,000 216,801,000 223,743,000 197,768,000 238,009,000 204,028,000 203,359,000 184,346,000 243,725,000 191,538,000 178,572,000 192,318,000 104,584,000 52,870,000 57,535,000 81,317,000 61,441,000 59,936,000 58,100,000 56,284,000 69,911,000 59,241,000 38,110,000 50,208,000 168,530,000 173,491,000 66,440,000 70,303,000 74,722,000 36,856,000 31,360,000 31,627,000 
        long-term debt, less current portion
      4,328,354,000 4,331,982,000 4,335,616,000 5,336,481,000 6,077,640,000 6,080,802,000 5,100,983,000 5,105,111,000 5,107,988,000 5,110,757,000 5,686,646,000 5,689,662,000 5,693,341,000 5,695,814,000 5,989,998,000 5,992,868,000 6,018,943,000 6,247,287,000 6,489,315,000 1,853,033,000 1,848,516,000 1,843,685,000 2,069,669,000 1,576,984,000 1,573,870,000 1,570,781,000 1,567,842,000 1,565,277,000 1,563,025,000 1,560,582,000 1,558,314,000 1,537,044,000 1,540,433,000 1,543,819,000 1,635,800,000 1,739,594,000 1,993,531,000 2,147,379,000 1,141,652,000 1,146,433,000 1,166,916,000 1,172,103,000 1,337,986,000 1,334,661,000 1,333,000,000 1,331,340,000 1,186,960,000 1,189,096,000 544,404,000 545,564,000 546,724,000 418,506,000 427,073,000 435,631,000 444,190,000     20,569,000 24,629,000 28,670,000 32,694,000             
        operating lease liabilities, less current portion
      50,892,000 53,426,000 55,107,000 38,780,000 38,938,000 71,115,000 67,617,000 56,158,000 59,225,000 61,892,000 65,547,000 72,095,000 71,838,000 72,984,000 77,845,000 83,078,000 87,200,000 89,359,000 156,556,000 136,020,000 140,035,000 141,925,000 144,264,000 147,110,000 151,226,000 153,434,000 156,289,000 154,066,000                                                
        deferred tax liabilities
      594,470,000 629,033,000 682,123,000 670,801,000 676,736,000 791,784,000 775,228,000 809,714,000 847,706,000 841,234,000 910,724,000 932,247,000 944,337,000 933,670,000 1,096,416,000 1,222,084,000 1,300,541,000 1,329,184,000 1,421,027,000 109,915,000 130,397,000 141,588,000 162,376,000 165,095,000 224,095,000 250,167,000 283,669,000 296,148,000 309,097,000 337,021,000 354,932,000 382,072,000 383,472,000                                           
        other non-current liabilities
      124,519,000 108,912,000 93,731,000 91,119,000 86,614,000 110,971,000 99,416,000 97,425,000 104,751,000 127,480,000 126,683,000 109,178,000 106,812,000 123,935,000 129,420,000 124,644,000 116,998,000 137,806,000 132,507,000 105,868,000 101,148,000 142,475,000 134,839,000 117,258,000 109,374,000 102,583,000 120,713,000 111,897,000 218,879,000 208,647,000 205,731,000 192,181,000 176,608,000 158,497,000 144,690,000 128,809,000 112,617,000 106,101,000 94,196,000 79,207,000 69,253,000 59,666,000 52,664,000 45,122,000 38,393,000 33,596,000 29,175,000 25,395,000 20,040,000 16,747,000 13,330,000 9,817,000 6,621,000 2,161,000 1,615,000 1,314,000                    
        commitments and contingencies
                                                                                 
        shareholders’ equity:
                                                                                 
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 61,435 and 60,631 shares issued and outstanding at december 31, 2025 and 2024, respectively
      6,000                                                                           
        non-voting euro deferred shares, €0.01 par value per share...
      55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000    55,000                       
        capital redemption reserve
      473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000                    
        additional paid-in capital
      4,240,472,000 4,085,669,000 4,000,280,000 3,925,161,000 3,913,542,000 3,837,698,000 3,779,114,000 3,714,283,000 3,699,954,000 3,639,940,000 3,580,115,000 3,511,732,000 3,477,124,000 3,387,997,000 3,312,319,000 3,239,327,000 3,534,792,000 3,469,884,000 3,403,482,000 2,694,858,000 2,633,670,000 2,537,989,000 2,499,135,000 2,294,474,000 2,266,026,000 2,209,156,000 2,171,458,000 2,130,738,000 2,113,630,000 2,078,032,000 2,037,091,000 1,955,756,000 1,935,486,000 1,899,628,000 1,720,584,000 1,681,774,000 1,665,232,000 1,635,431,000 1,617,069,000 1,586,750,000 1,562,900,000 1,534,032,000 1,512,450,000 1,488,262,000 1,458,005,000 1,431,790,000 1,273,159,000 1,251,587,000 1,220,317,000 1,201,221,000 1,184,965,000 1,168,633,000 1,151,010,000 1,133,542,000 1,126,371,000 1,103,498,000 542,697,000 528,682,000 521,429,000 513,108,000 505,413,000 498,516,000 496,263,000 437,179,000 434,811,000 430,852,000 422,724,000 421,497,000 407,923,000 405,689,000 379,437,000 375,607,000 371,440,000 368,136,000 366,165,000 
        accumulated other comprehensive loss
      -568,598,000 -569,898,000 -485,768,000 -785,610,000 -947,667,000 -603,397,000 -888,227,000 -882,394,000 -842,147,000 -1,035,399,000 -866,823,000 -980,230,000 -1,125,509,000 -1,617,646,000 -1,106,029,000 -590,720,000 -400,360,000 -397,517,000 -190,935,000 -179,428,000 -134,352,000 -187,801,000 -236,109,000 -257,436,000 -223,393,000 -259,442,000 -210,436,000 -220,674,000 -197,791,000 -179,466,000 -168,228,000 -98,768,000 -140,878,000 -158,987,000 -210,249,000 -299,843,000 -317,333,000 -235,376,000 -249,988,000 -222,284,000 -267,472,000 -231,277,000 -248,042,000 -278,584,000           -388,000  -31,000 -2,000                  
        retained earnings
      646,176,000 442,725,000 191,313,000 1,034,806,000 1,127,347,000 936,232,000 871,178,000 864,038,000 878,656,000 884,298,000 811,849,000 803,006,000 733,586,000 974,310,000 993,958,000 959,347,000 830,226,000 865,577,000 918,410,000 1,281,726,000 1,159,894,000 1,026,480,000 878,246,000 770,929,000 1,067,815,000 1,104,158,000 1,021,879,000 819,850,000 841,050,000 1,128,218,000 1,000,356,000 929,050,000 917,956,000 728,123,000 690,164,000 601,522,000 528,907,000 315,415,000 324,844,000 242,441,000 302,686,000 260,176,000 181,828,000 95,066,000 34,704,000 -34,666,000 -53,946,000 -74,118,000 18,532,000                           
        total shareholders’ equity
      4,318,584,000 3,959,030,000 3,706,359,000 4,174,891,000 4,093,756,000 4,171,067,000 3,762,599,000 3,696,461,000 3,736,997,000 3,489,373,000 3,525,675,000 3,335,041,000 3,085,734,000 2,745,194,000 3,200,781,000 3,608,487,000 3,965,191,000 3,938,477,000 4,131,490,000 3,797,689,000 3,659,745,000 3,377,201,000 3,141,805,000 2,808,500,000 3,110,981,000 3,054,405,000 2,983,434,000 2,730,447,000 2,757,422,000 3,027,317,000 2,869,752,000 2,786,571,000 2,713,097,000 2,469,297,000 2,201,032,000 1,983,986,000 1,877,339,000 1,716,003,000 1,692,458,000 1,607,440,000 1,598,646,000 1,563,477,000 1,446,823,000 1,305,330,000 1,371,208,000 1,340,613,000 1,280,087,000  1,295,534,000 1,243,701,000 1,175,453,000 1,161,900,000 1,121,292,000 886,087,000 831,459,000 781,832,000                    
        total liabilities and shareholders’ equity
      11,659,340,000 11,356,485,000 10,944,141,000 11,534,682,000 12,012,257,000 12,255,716,000 11,361,868,000 11,327,075,000 11,393,359,000 11,204,065,000 11,260,540,000 11,047,125,000 10,835,255,000 10,384,667,000 11,200,133,000 11,768,917,000 12,298,639,000 12,478,152,000 13,212,993,000 6,756,470,000 6,535,901,000 6,291,958,000 6,066,501,000 5,215,295,000 5,538,897,000 5,527,850,000 5,488,661,000 5,280,235,000 5,203,491,000 5,485,788,000 5,348,967,000 5,287,128,000 5,123,672,000 4,999,024,000 4,804,024,000 4,815,824,000 4,800,227,000 4,930,581,000 3,448,094,000 3,534,979,000 3,359,663,000 3,464,300,000 3,393,274,000 3,237,593,000 3,338,955,000 3,347,536,000 3,155,749,000 3,196,434,000 2,238,221,000 2,185,499,000 2,093,880,000 2,009,690,000 1,966,493,000 1,726,699,000 1,697,944,000 895,360,000                    
        ordinary shares
       6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000                    
        non-voting euro deferred shares
       55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000                    
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 60,631 and 62,255 shares issued and outstanding at december 31, 2024 and 2023, respectively
          6,000                                                                       
        deferred revenue
               4,000 4,000 4,000 463,000 871,000 1,278,000 1,686,000 2,093,000 2,267,000 2,441,000 2,373,000 2,546,000 3,090,000 3,633,000 4,176,000 4,720,000 4,720,000 4,720,000 4,720,000 5,414,000 5,935,000 6,456,000 6,977,000 8,618,000 8,618,000 8,575,000 8,590,000 1,123,000 1,499,000 1,432,000 1,378,000 1,370,000 1,330,000 1,330,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,943,000 2,011,000 1,138,000 1,138,000 1,138,000 1,366,000 1,561,000 1,273,000 3,412,000 3,424,000 3,208,000 2,675,000 2,500,000 2,349,000 12,605,000 12,322,000 12,400,000 3,430,000 1,494,000 1,494,000 1,999,000 2,027,000 
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 62,255 and 63,214 shares issued and outstanding at december 31, 2023 and 2022, respectively
              6,000                                                                   
        deferred revenue, non-current
                   116,000 231,000 347,000 463,000 986,000 1,510,000 1,852,000 2,315,000 2,951,000 3,588,000 4,225,000 4,861,000 6,041,000 7,221,000 8,401,000 9,581,000 10,934,000 12,288,000 13,641,000 16,115,000 18,270,000 20,470,000 22,624,000 2,601,000 2,881,000 3,161,000 3,441,000 3,721,000 3,646,000 3,930,000 4,215,000 4,499,000 4,784,000 5,148,000 5,433,000 5,718,000 6,001,000 6,283,000 6,566,000 6,776,000 7,129,000 7,356,000 7,630,000 7,915,000 8,199,000 8,484,000 8,768,000 9,053,000 9,338,000 9,622,000 9,907,000 10,191,000         12,752,000 13,037,000 
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 63,214 and 61,633 shares issued and outstanding at december 31, 2022 and 2021, respectively
                  6,000                                                               
        assets held for sale
                     90,888,000               78,033,000              32,833,000         59,546,000                      
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 61,633 and 56,171 shares issued and outstanding at december 31, 2021 and 2020, respectively
                      6,000                                                           
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 56,171 and 56,140 shares issued and outstanding at december 31, 2020 and 2019, respectively
                          6,000                                                       
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 56,140 and 57,504 shares issued and outstanding at december 31, 2019 and 2018, respectively
                              6,000                                                   
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 57,504 and 59,898 shares issued and outstanding at december 31, 2018 and 2017, respectively
                                  6,000                                               
        property and equipment
                                      170,080,000 159,386,000 136,626,000 119,913,000 107,490,000 99,898,000 93,476,000 86,788,000 85,572,000 83,452,000 80,428,000 71,283,000 58,363,000 44,205,000 38,462,000 30,048,000 14,246,000 12,060,000 10,768,000 7,795,000 7,281,000 6,671,000 4,631,000 2,026,000 1,557,000 930,000 647,000 652,000 690,000 716,000 901,000 909,000 1,124,000 1,444,000 1,778,000 2,140,000 2,514,000 3,708,000 4,260,000 3,875,000 3,941,000 3,286,000 3,025,000 
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 59,898 and 59,820 shares issued and outstanding at december 31, 2017 and 2016, respectively
                                      6,000                                           
        deferred tax assets, net, non-current
                                       23,662,000 20,158,000 18,038,000 15,060,000  117,507,000 122,036,000 122,863,000 76,391,000 73,280,000 74,185,000 75,494,000 101,249,000 96,495,000 94,250,000 74,597,000 70,976,000 65,136,000 62,933,000 74,850,000                       
        deferred tax liability, net, non-current
                                       540,964,000 551,639,000 548,038,000 556,733,000 725,358,000 289,906,000 299,627,000 294,485,000 325,216,000 326,707,000 327,683,000 375,054,000 413,460,000 456,611,000 471,993,000 168,497,000 170,127,000 167,744,000 169,176,000 178,393,000                       
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 59,820 and 61,305 shares issued and outstanding at december 31, 2016 and 2015, respectively
                                          6,000                                       
        deferred tax liability
                                               9,417,000 9,438,000 9,430,000 9,430,000 6,259,000 6,259,000 6,259,000 6,259,000 275,000 259,000 259,000 275,000 180,919,000 185,706,000                     
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 61,305 and 60,643 shares issued and outstanding at december 31, 2015 and 2014, respectively
                                              6,000                                   
        total jazz pharmaceuticals plc shareholders’ equity
                                              1,598,646,000 1,563,463,000 1,446,768,000 1,305,276,000 1,371,144,000 1,340,523,000 1,279,691,000 1,248,893,000                            
        noncontrolling interests
                                               14,000 55,000 54,000 64,000 90,000 396,000 17,615,000                            
        jazz pharmaceuticals plc shareholders' equity
                                                                                 
        contingent consideration
                                                      50,000,000 47,700,000 42,700,000 39,300,000 34,800,000 36,200,000 35,300,000                     
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 60,643 and 57,854 shares issued and outstanding at december 31, 2014 and 2013, respectively
                                                  6,000                               
        accumulated other comprehensive income
                                                  -122,097,000 -57,133,000 59,946,000 70,892,000 56,153,000 44,622,000 19,220,000 10,606,000 31,046,000 13,860,000  3,000             4,000 -3,000  12,000 19,000 1,000  
        total shareholders' equity
                                                     1,266,508,000                            
        contingent consideration, non-current
                                                                                 
        ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 57,854 and 58,014 shares issued and outstanding at december 31, 2013 and 2012, respectively
                                                      6,000                           
        accumulated deficit
                                                       -2,674,000 -29,264,000 -17,871,000 -61,296,000 -261,847,000 -295,056,000 -322,201,000 -349,882,000 -387,355,000 -419,837,000 -453,039,000 -474,866,000 -499,325,000 -512,568,000 -506,180,000 -507,644,000 -513,297,000 -511,625,000 -513,796,000 -500,808,000 -443,868,000 -415,058,000 -363,179,000 -316,469,000 -256,449,000 -237,090,000 
        other long-term assets
                                                         4,546,000 3,662,000 20,405,000 19,226,000 385,000 87,000 83,000 152,000 302,000 335,000 371,000 310,000 1,040,000 1,247,000 1,456,000 1,886,000 246,000 246,000 2,505,000 2,848,000 2,766,000 1,269,000 1,541,000 1,440,000 
        marketable securities
                                                             73,564,000 75,822,000 12,133,000           1,004,000 999,000 1,500,000 4,410,000  10,939,000  
        purchased product rights liability
                                                           5,743,000 6,972,000 15,191,000 4,500,000 4,875,000 4,750,000 4,625,000 4,500,000 4,375,000 4,250,000 4,125,000 4,000,000 6,000,000 7,000,000 6,000,000 14,000,000 21,000,000 21,000,000 31,000,000    
        liability under government settlement
                                                              7,320,000 7,225,000 7,130,000 8,202,000 4,128,000 4,002,000 2,715,000 2,594,000 2,954,000   10,658,000 13,063,000 13,063,000 13,063,000 13,063,000 14,881,000   
        preferred stock, 0.0001 par value per share...
                                                                                 
        ordinary shares, nominal value 0.0001 per share; 300,000 and 150,000 shares authorized; 58,014 and 42,468 shares issued and outstanding at december 31, 2012 and 2011, respectively
                                                          6,000                       
        restricted cash
                                                                 400,000 400,000 400,000 910,000 951,000 2,988,000 950,000 1,075,000 775,000 1,913,000 1,998,000 1,998,000 1,998,000 1,939,000 304,000 275,000 
        liabilities and stockholders’ equity
                                                                                 
        revolving credit facility
                                                                4,000,000 4,000,000 7,350,000 7,350,000 7,350,000             
        purchased product rights liability, non-current
                                                               750,000 2,000,000 3,250,000 4,500,000 5,625,000 6,750,000 7,875,000 9,000,000           
        liability under government settlement, non-current
                                                                  6,978,000 6,978,000 8,142,000 8,142,000 10,658,000         14,881,000 14,881,000 
        deferred rent
                                                                12,000 77,000 82,000 86,000 73,000 51,000 29,000 7,000          
        stockholders’ equity:
                                                                                 
        preferred stock, 0.0001 par value...
                                                                                 
        common stock, 0.0001 par value...
                                                              4,000    4,000    3,000    3,000    2,000   
        total stockholders’ equity
                                                              192,788,000 141,329,000 101,596,000 60,073,000 30,551,000        -92,878,000 -38,179,000 -35,619,000 12,442,000 54,992,000 111,690,000 129,077,000 
        total liabilities and stockholders’ equity
                                                              253,573,000 207,813,000 193,409,000 154,178,000 135,729,000        117,498,000 179,793,000 186,591,000 239,018,000    
        common stock
                                                               4,000 4,000 4,000  4,000 4,000 3,000  3,000 3,000 3,000  3,000 2,000 2,000  2,000 2,000 
        stockholders’ equity
                                                                                 
        liabilities and stockholders’ deficit
                                                                                 
        stockholders’ deficit:
                                                                                 
        total stockholders’ deficit
                                                                   -805,000 -16,301,000 -68,998,000 -72,830,000 -82,442,000 -88,898,000 -92,296,000        
        total liabilities and stockholders’ deficit
                                                                   107,992,000 97,264,000 106,706,000 107,396,000 102,172,000 108,574,000 109,937,000        
        line of credit
                                                                     7,840,000 9,399,000 3,000,000   3,875,000 3,265,000 6,099,000 3,180,000 3,459,000 2,597,000 3,134,000 
        senior secured notes
                                                                     32,891,000 23,759,000  14,638,000 123,970,000 118,534,000 113,614,000 113,704,000 113,367,000 75,116,000 74,862,000 74,622,000 
        common stock subject to repurchase
                                                                          12,492,000 13,241,000 13,241,000 13,241,000 13,241,000 13,222,000 13,174,000 
        purchased product rights liability, noncurrent
                                                                       10,000,000 11,000,000 12,000,000        
        deferred revenue, noncurrent
                                                                       10,476,000 10,761,000 11,045,000        
        liability under government settlement, noncurrent
                                                                       10,658,000 10,658,000         
        long-term restricted cash and investments
                                                                              12,000,000 12,085,000 12,085,000 
        non-current portion of deferred revenue
                                                                          11,330,000 11,614,000 11,899,000 12,183,000 12,468,000   
        liabilities, convertible preferred stock, and stockholders’ equity
                                                                                 
        preferred stock warrant liability
                                                                                 
        liability for early exercise of options and unvested restricted common stock
                                                                                 
        convertible preferred stock, 0.0001 par value...
                                                                                 
        total liabilities, convertible preferred stock and stockholders’ equity
                                                                              207,554,000 258,767,000 276,870,000 
        liabilities, convertible preferred stock and stockholders’ equity
                                                                                 
        deferred rent and other non-current liabilities
                                                                                452,000 
        convertible preferred stock
                                                                                 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 
                                                                                  
          operating activities
                                                                                  
          net income
        203,451,000 251,412,000   191,115,000 215,055,000 168,568,000 -14,618,000 94,154,000 146,820,000 104,438,000 69,420,000 -240,724,000 -19,648,000 34,665,000 1,647,000 -35,351,000   121,832,000 133,414,000 148,234,000 114,801,000 -157,833,000 73,992,000 102,276,000 261,898,000 85,201,000 159,470,000 149,316,000 92,321,000 45,991,000 232,207,000 63,526,000 105,604,000 86,511,000 124,283,000 87,145,000 111,282,000 74,121,000 82,761,000 87,960,000 88,113,000 70,700,000 81,611,000 25,768,000 43,586,000 -93,639,000 55,293,000 75,409,000 42,185,000 43,425,000 200,551,000 33,209,000 27,145,000 27,681,000 37,473,000 32,482,000 33,202,000 21,827,000 24,459,000   1,464,000           
          adjustments to reconcile net income to net cash from operating activities:
                                                                                  
          acquired in-process research and development
        42,500,000   10,000,000 18,000,000 1,000,000 375,000,000       36,000,000 10,000,000 3,000,000 202,250,000 51,775,000 2,200,000 56,000,000     8,000,000 75,000,000   15,000,000 8,750,000     626,000 75,000,000 127,000,000                           
          intangible asset amortization
        169,742,000 168,368,000 162,103,000 154,448,000 158,903,000 157,457,000 155,223,000 155,730,000 151,553,000 154,883,000 152,062,000 149,786,000 137,387,000 141,232,000 148,456,000 172,094,000 157,293,000 159,804,000 140,480,000 68,192,000 67,075,000 66,684,000 62,974,000 62,847,000 173,490,000 62,863,000 61,576,000 56,885,000 46,543,000 46,989,000 54,959,000 53,007,000 52,901,000 47,313,000 26,186,000 25,665,000 26,162,000 26,453,000 26,737,000 22,642,000 23,690,000 26,127,000 23,668,000 24,677,000                               
          share-based compensation
        70,854,000 88,125,000 64,501,000 67,653,000 70,190,000 59,760,000 56,654,000 61,441,000 52,941,000 56,115,000 61,433,000 56,352,000 61,558,000 56,681,000 53,687,000 50,070,000 53,119,000 53,239,000 48,163,000 34,485,000 31,384,000 30,356,000 30,604,000 28,654,000 25,937,000 28,785,000 28,289,000 27,552,000 26,723,000 25,103,000 26,312,000 24,303,000 27,321,000 27,126,000 27,260,000 25,193,000 24,281,000 24,874,000 25,433,000 24,183,000 24,317,000 23,114,000 23,300,000 20,819,000 19,020,000 18,251,000 18,552,000 13,815,000 12,412,000 11,876,000 11,506,000 8,757,000                       
          acquisition accounting inventory fair value step-up adjustment
        40,604,000 40,355,000 37,109,000 29,880,000 37,794,000 35,034,000 33,243,000 28,943,000 32,352,000 30,822,000 27,814,000 60,458,000 70,203,000 70,964,000 68,282,000 63,943,000 74,448,000 82,646,000                                                         
          depreciation
        9,427,000 9,878,000 11,906,000 10,425,000 9,514,000 7,775,000 7,812,000 7,653,000 7,648,000 7,675,000 7,515,000 7,574,000 7,344,000 7,594,000 7,747,000 7,617,000 7,327,000 7,773,000 6,835,000 4,779,000 4,597,000 4,810,000 4,739,000 4,527,000 4,457,000 3,991,000 3,355,000 3,539,000 3,870,000 3,906,000 3,735,000 3,722,000 3,801,000 3,065,000 3,093,000 3,130,000 3,621,000 3,121,000 2,517,000 2,527,000 2,751,000 2,548,000 2,363,000 2,232,000 2,060,000 1,868,000 1,860,000 1,309,000 983,000 895,000 595,000 575,000 518,000 374,000 229,000 186,000 111,000 79,000 85,000 104,000 173,000 188,000 224,000 301,000 326,000 364,000 369,000 370,000 438,000 609,000 627,000 524,000   
          non-cash interest expense
        5,329,000 5,299,000 4,848,000 17,066,000 3,096,000 7,677,000 5,212,000 5,988,000 6,123,000 6,062,000 5,427,000 4,766,000 5,971,000 14,262,000 5,572,000 12,168,000 26,600,000 28,045,000                                                  535,000 625,000 592,000 513,000 330,000   
          provision for losses on accounts receivable and inventory
        4,114,000 8,223,000 1,452,000 5,319,000 11,892,000 2,680,000 5,783,000 7,403,000 3,381,000 2,182,000 3,234,000 2,316,000 1,471,000 6,916,000 3,980,000 2,170,000 6,224,000 4,702,000 7,659,000 1,083,000 5,852,000 5,070,000 1,458,000 2,620,000 2,821,000 1,444,000 1,875,000 528,000 -6,000 2,064,000 2,080,000 590,000 365,000 277,000 600,000 948,000 445,000 76,000 790,000 898,000 41,000 3,411,000 184,000 426,000 -380,000 948,000 1,112,000 813,000 688,000 522,000 1,094,000 142,000 1,958,000                      
          deferred tax benefit
        -63,309,000 -271,410,000 -66,419,000 -43,833,000 -2,355,000 -64,404,000 -75,183,000 -66,385,000  -78,922,000 -79,334,000 -66,061,000    -45,339,000    -19,110,000 -16,028,000 -38,141,000 -18,792,000 -63,976,000 -68,675,000 -16,588,000 -134,294,000 -17,053,000                                               
          impairment of property, plant and equipment
                                                                                  
          other non-cash transactions
        -4,955,000 1,016,000 13,579,000 -6,537,000 -1,637,000 4,095,000 846,000 14,674,000 -42,919,000 6,106,000 31,383,000 16,773,000 11,866,000 2,743,000 -14,394,000 -14,701,000 410,000 6,639,000 -4,783,000 7,766,000 1,908,000 9,176,000 1,594,000 1,902,000 386,000 -1,890,000 -3,728,000 1,181,000 -2,471,000 -4,026,000 -5,030,000 16,026,000 -159,000 6,480,000 6,595,000 1,405,000 -5,201,000 493,000 -612,000 1,579,000 -1,353,000 -11,772,000 7,306,000 632,000 1,518,000 -2,686,000 1,039,000 1,868,000 1,843,000 1,184,000 1,276,000 1,975,000 1,752,000 1,462,000 -2,102,000 2,411,000                   
          changes in assets and liabilities:
                                                                                  
          accounts receivable
        -65,813,000 -50,996,000 -55,519,000 66,049,000 864,000 -22,256,000 8,720,000 -8,443,000 -75,464,000 -18,858,000 13,979,000 28,460,000 -46,267,000 -9,637,000 -24,508,000 -9,723,000 -64,779,000 6,882,000 -16,593,000 -18,245,000 -33,643,000 -8,644,000 -34,221,000 37,861,000 -88,019,000 43,267,000 9,386,000 -56,960,000 15,386,000 -1,162,000 2,235,000 -56,591,000 34,551,000 -19,235,000 5,445,000 -8,483,000 2,671,000 -6,116,000 -8,356,000 -13,802,000 -14,180,000 -2,182,000 -3,710,000 -4,769,000 -4,351,000 -28,801,000 -5,875,000 -16,014,000 -11,197,000 1,366,000 -20,104,000 -18,911,000 13,049,000 -10,346,000 1,367,000 -8,794,000 -2,946,000 -6,429,000 -3,616,000 698,000 -7,967,000 -19,000 -2,140,000 358,000 -3,111,000 -5,000 -2,185,000 -369,000 43,000 -1,465,000 89,000 79,000 927,000 -104,000 
          inventories
        7,720,000 -31,909,000 -26,231,000 -35,621,000 -18,665,000 -9,286,000 -4,747,000 -12,844,000 -1,404,000 -4,934,000 -816,000 -6,266,000 816,000 -8,529,000 -17,117,000 -24,812,000 -14,970,000 -4,489,000 -7,388,000 -22,014,000 -8,676,000 -3,035,000 -8,591,000 -10,235,000 -9,762,000 -4,466,000 -9,874,000 -8,688,000 -10,929,000 1,355,000 -5,626,000 -3,312,000 -1,535,000 -1,253,000 -1,621,000 -4,258,000 -2,907,000 933,000 -8,743,000 -6,307,000 9,866,000 -1,746,000 -7,000 -1,842,000 2,554,000 -6,882,000 -231,000 -3,071,000 -5,071,000 2,659,000 -7,335,000 1,231,000 -18,000 909,000 864,000 -58,000 506,000 440,000 302,000 50,000 -613,000 -49,000 -911,000 -71,000 631,000 -329,000 223,000 358,000 1,450,000 -56,000 -4,038,000 10,000 1,026,000 -2,000 
          prepaid expenses and other assets
                                                                                  
          accounts payable
        -28,972,000 62,358,000 -12,666,000 19,131,000 -3,135,000 -12,790,000 15,449,000 -19,597,000 -8,102,000 10,243,000 -26,824,000 34,286,000 -15,413,000 28,959,000 2,846,000 -27,617,000 37,854,000 -142,000 -31,983,000 51,292,000 -39,580,000 15,381,000 -14,340,000 19,604,000 -24,334,000 43,200,000 -15,650,000 1,554,000 6,924,000 2,745,000 -15,765,000 23,136,000 -5,916,000 783,000 -518,000 5,865,000 4,649,000 -10,512,000 -4,440,000 10,664,000 -7,106,000 2,697,000 -1,174,000 3,303,000 -4,101,000 -2,310,000 -40,134,000 8,579,000 -1,581,000 1,963,000 -11,451,000 16,158,000 -4,743,000 -13,906,000 6,714,000 4,649,000 -3,334,000 3,798,000 1,017,000 599,000 -842,000 -2,512,000 2,518,000 1,727,000 -3,082,000 1,166,000 -480,000 -1,182,000 -878,000 -1,908,000 -393,000 6,059,000 -16,000 -1,036,000 
          accrued liabilities
        26,170,000 126,277,000 -256,389,000 181,038,000 29,731,000 51,024,000 -29,273,000 34,677,000 53,016,000 13,547,000 7,177,000 -96,985,000 148,127,000 62,294,000 -21,189,000 -23,241,000 48,821,000 36,846,000 42,969,000 13,719,000 52,967,000 33,482,000 5,226,000 -12,198,000 31,804,000 21,662,000 -56,346,000 -2,685,000 6,134,000 4,966,000 12,624,000 47,484,000 17,005,000 9,489,000 -17,329,000 -15,743,000 19,781,000 -4,058,000 1,117,000 -6,706,000 -1,656,000 22,777,000 -650,000 -17,485,000 1,529,000 20,289,000 -1,748,000 927,000 13,155,000 9,311,000 -5,089,000 -2,660,000 -13,970,000 -4,012,000 22,878,000 -6,539,000 -1,051,000 9,121,000 3,439,000 -298,000 4,497,000 3,171,000 536,000 1,072,000 2,707,000 -5,409,000 597,000 -90,000 -655,000 -7,947,000 2,753,000 476,000 5,501,000 1,820,000 
          income taxes payable
        -34,784,000 12,738,000 46,282,000 12,988,000 -34,840,000 2,068,000 3,172,000 14,858,000 -35,939,000 15,222,000 20,524,000 25,413,000 -1,520,000 4,296,000 -21,235,000 16,767,000 -24,695,000 31,010,000 -46,464,000 24,625,000 -2,051,000 -30,392,000 24,652,000 20,829,000 -32,757,000 13,763,000 -10,676,000 39,726,000 -5,736,000 -10,714,000 -17,468,000 14,183,000 7,836,000 6,008,000 -28,266,000 30,753,000 -361,000 -75,000 -22,360,000 25,758,000 -15,264,000 2,496,000 -23,666,000 30,163,000 -10,369,000 13,549,000 -303,000 5,757,000 -19,898,000 2,812,000 -20,501,000 -1,397,000                       
          other liabilities
                                                                                  
          net cash from operating activities
        362,518,000 474,616,000 88,855,000 429,784,000 398,580,000 398,747,000 331,352,000 267,229,000 167,339,000 307,195,000 296,765,000 320,708,000 341,971,000 417,991,000 303,036,000 208,979,000 177,755,000 274,060,000 41,695,000 284,997,000 186,271,000 257,889,000 182,519,000 272,969,000 87,798,000 337,503,000 148,847,000 202,253,000 224,346,000 220,575,000 191,624,000 162,359,000 204,559,000 188,897,000 135,091,000 164,540,000 180,695,000 136,531,000 129,594,000 143,716,000 119,741,000 175,076,000 140,571,000 96,555,000 132,421,000 129,697,000 74,924,000 68,723,000 79,207,000 129,800,000 8,719,000 65,890,000 104,345,000 44,143,000 76,969,000 24,295,000 43,659,000 46,053,000 37,436,000 24,448,000 31,275,000 18,486,000 2,607,000 6,500,000 1,772,000 -11,442,000 -1,058,000 -5,150,000 -18,786,000 -28,689,000 -44,587,000 -38,170,000 -28,061,000 -15,371,000 
          capital expenditures
        -16,729,000 -15,175,000 -12,967,000 -13,881,000 -13,287,000 -10,788,000 -7,091,000 -6,904,000 -10,102,000 -4,299,000 -5,739,000 -3,822,000 -9,378,000 4,902,000 -12,278,000 -12,292,000 -9,967,000 -8,328,000 -7,178,000 -2,168,000 -4,115,000 -3,369,000 -2,690,000 -4,830,000 -7,137,000 -11,087,000 -13,963,000 -7,948,000 -5,149,000 -3,940,000 -4,132,000 -7,149,000 -8,878,000 -8,347,000 -8,151,000 -3,574,000 -1,277,000 -2,382,000 -1,701,000 -2,472,000 -3,367,000 -5,159,000 -13,022,000 -14,410,000 -13,548,000 -8,139,000 -11,133,000 -3,527,000 -3,102,000 -2,164,000 -3,567,000 -1,143,000 -983,000 -2,499,000 -2,209,000 -285,000 -756,000 -362,000 -95,000 -66,000 -113,000 -316,000 -216,000 -86,000 -6,000 -30,000 -12,000 -5,000 -74,000 -56,000 -1,151,000 -458,000 -1,043,000 -593,000 
          free cash flows
        345,789,000 459,441,000 75,888,000 415,903,000 385,293,000 387,959,000 324,261,000 260,325,000 157,237,000 302,896,000 291,026,000 316,886,000 332,593,000 422,893,000 290,758,000 196,687,000 167,788,000 265,732,000 34,517,000 282,829,000 182,156,000 254,520,000 179,829,000 268,139,000 80,661,000 326,416,000 134,884,000 194,305,000 219,197,000 216,635,000 187,492,000 155,210,000 195,681,000 180,550,000 126,940,000 160,966,000 179,418,000 134,149,000 127,893,000 141,244,000 116,374,000 169,917,000 127,549,000 82,145,000 118,873,000 121,558,000 63,791,000 65,196,000 76,105,000 127,636,000 5,152,000 64,747,000 103,362,000 41,644,000 74,760,000 24,010,000 42,903,000 45,691,000 37,341,000 24,382,000 31,162,000 18,170,000 2,391,000 6,414,000 1,766,000 -11,472,000 -1,070,000 -5,155,000 -18,860,000 -28,745,000 -45,738,000 -38,628,000 -29,104,000 -15,964,000 
          investing activities
                                                                                  
          acquisition of investments
        -510,100,000 -640,125,000 -240,000,000 -440,050,000 -470,000,000 -130,125,000 -330,000,000 -375,000,000 -120,100,000 -190,000,000   -300,000   -125,000 -594,000 -5,400,000 -20,700,000 -735,925,000 -621,275,000 -855,475,000 -185,000,000 -331,125,000 -225,000,000 -245,975,000 -115,000,000 -250,915,000 -415,000,000 -265,000,000 -235,000,000 -95,000,000 -270,000,000   -582,000 -11,209,000 -52,711,000 -773,000                                   
          asset acquisition, net of cash acquired
                                                                               
          acquisition of intangible assets
        -53,500,000 -30,000,000 -25,000,000         -25,000,000    -100,000,000 -13,000,000 -55,000,000   2,000                                         
          purchases of property, plant and equipment
        -16,729,000 -15,175,000 -12,967,000 -13,881,000 -13,287,000 -10,788,000 -7,091,000 -6,904,000 -10,102,000 -4,299,000 -5,739,000 -3,822,000 -9,378,000 4,902,000 -12,278,000 -12,292,000 -9,967,000 -8,328,000 -7,178,000 -2,168,000 -4,115,000 -3,369,000 -2,690,000 -4,830,000 -7,137,000 -11,087,000 -13,963,000 -7,948,000 -5,149,000 -3,940,000 -4,132,000 -7,149,000                                           
          proceeds from sale of an asset
                                                                                  
          proceeds from maturity of investments
        180,000,000 400,000,000 470,000,000 310,000,000 290,000,000 355,000,000 80,000,000 120,000,000 250,000,000        335,000,000 760,000,000 835,000,000 355,000,000 220,000,000 345,000,000 165,000,000 190,000,000 285,000,000 345,000,000 290,000,000 180,000,000 190,000,000 195,000,000 80,000,000                                          
          net cash from investing activities
        -372,162,000 -327,800,000 -641,020,000 -168,931,000 -193,287,000 214,087,000 -257,091,000 -271,904,000 101,798,000 -174,299,000 -85,739,000 -4,822,000 -324,378,000 4,602,000 -89,162,000 -37,292,000 -10,092,000 -26,813,000 -5,912,370,000 737,132,000 73,219,000 -279,644,000 -741,165,000 -60,080,000 -159,053,000 -159,661,000 -2,638,000 166,052,000 33,742,000 -190,846,000 -190,234,000 -47,149,000 -31,878,000 -203,347,000 -30,151,000 -3,574,000 -1,859,000 -1,531,034,000 -204,412,000 -11,995,000 -3,367,000 -5,159,000 -12,022,000 18,293,000 -14,174,000 -83,139,000 -13,133,000 -957,203,000 -3,102,000 -2,164,000 -3,567,000 -2,443,000 87,189,000 -3,749,000 -561,242,000 82,508,000 -65,599,000 -13,622,000 -820,000 -1,191,000 -1,113,000 -806,000 -1,175,000 951,000 -5,044,000 -1,905,000 -312,000 1,137,000 -6,994,000 6,220,000 -8,241,000 -2,927,000 9,405,000 -11,470,000 
          financing activities
                                                                                  
          repayments of long-term debt
        -7,750,000 -7,750,000 -7,750,000 -757,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -7,750,000 -307,746,000 -7,754,000 -258,764,000 -258,760,000 -258,760,000 -575,921,000 -8,347,000 -8,347,000 -8,347,000 -8,346,000 -8,347,000 -8,347,000 -8,347,000 -8,346,000 -8,347,000 -8,347,000 -8,347,000 -9,023,000 -9,024,000 -9,023,000 -9,024,000 -9,023,000 -9,022,000 -9,885,000 -9,397,000 -9,397,000 -961,000 -893,118,000 -2,284,000 -2,434,000                              
          share repurchases
          -150,001,000   -99,795,000 -74,371,000         -7,484,000 -139,053,000 -110,335,000 -19,997,000 -59,869,000 -111,249,000 -446,657,000 -21,454,000 -21,015,000 -34,546,000 -42,374,000 -25,566,000 -16,963,000 -13,896,000 -18,477,000 -96,575,000 -28,879,000 -134,365,000 -40,251,000 -9,612,000 -1,352,000 -10,338,000 -12,242,000 -6,486,000   -34,087,000 -48,819,000                         
          payment of employee withholding taxes related to share-based awards
        -1,996,000 -3,812,000 -2,249,000 -67,163,000 -4,005,000 -1,605,000 -2,847,000 -49,296,000 -1,614,000 -1,884,000 -4,188,000 -43,266,000 -2,811,000 -2,567,000 -6,289,000 -33,776,000 -5,999,000 -2,431,000 -3,388,000 -23,784,000 -1,117,000 -1,097,000 -1,116,000 -13,547,000 -839,000 -1,087,000 -1,003,000 -13,810,000 -733,000 -1,169,000 -1,429,000 -14,594,000 -680,000 -1,589,000 -1,889,000 -14,431,000 -639,000 -6,317,000 -1,802,000 -12,476,000 -700,000 -8,723,000 -1,901,000 -14,778,000 -724,000 -6,755,000 -1,188,000 -9,363,000 -287,000 -3,706,000 -170,000 -1,427,000                       
          proceeds from employee equity incentive and purchase plans
        85,186,000 733,000 10,497,000 11,447,000 9,196,000 17,000 10,940,000 494,000 8,853,000 5,512,000 10,866,000 21,228,000 30,157,000 21,260,000 24,874,000 21,729,000 18,150,000 14,822,000 51,882,000 50,407,000 65,342,000 10,088,000 10,987,000 13,264,000 31,741,000 9,968,000 13,065,000 3,057,000 9,281,000 16,998,000 56,470,000 10,588,000 9,031,000 3,722,000    3,340,000                                     
          repayment of 2024 notes
                                                                                  
          payment of debt modification costs
                                                                                
          net proceeds from issuance of 2030 notes
                                                                                  
          net cash from financing activities
        75,440,000 -10,829,000 -124,525,000 -813,466,000 -8,275,000 246,428,000 -161,085,000 -56,552,000 -100,306,000 -78,493,000 -96,667,000 -29,788,000 19,596,000 -289,053,000 10,777,000 -270,811,000 -246,609,000 -465,181,000 4,664,036,000 18,276,000 55,878,000 -22,656,000 642,534,000 -147,683,000 -87,780,000 -19,463,000 -56,153,000 -130,349,000 -446,456,000 -13,972,000 28,873,000 -47,575,000 -39,984,000 27,028,000 -214,481,000 -181,674,000 -172,045,000 891,722,000 -34,170,000 -144,520,000 -123,861,000 -94,424,000 7,223,000 -3,261,000 -8,599,000 263,267,000 -39,455,000 497,662,000 -28,896,000 -45,722,000 47,456,000 3,133,000 3,590,000 -5,488,000 468,653,000 -18,225,000 2,801,000 -33,612,000 719,000 -2,990,000 -8,221,000 -4,401,000 -10,856,000 -4,048,000 6,637,000 9,805,000 127,000 -3,875,000 776,000 21,174,000 3,259,000 38,923,000 1,629,000 -1,187,000 
          effect of exchange rates on cash and cash equivalents
        33,000 203,000 4,624,000 1,695,000 -2,289,000 3,071,000 -759,000 -1,698,000 1,789,000 -1,017,000 34,000 331,000 4,935,000 -5,447,000 -4,221,000 -1,489,000 -1,386,000 -1,686,000 506,000 -641,000 459,000 271,000 592,000 -948,000 1,204,000 -943,000 217,000 -112,000 -1,028,000 -1,820,000 1,649,000 -501,000 723,000 824,000 1,759,000 1,740,000 -7,395,000 1,382,000 -2,826,000 3,794,000 -2,587,000 1,723,000 3,268,000 -13,026,000 -646,000 -3,040,000 45,000 188,000 833,000 2,241,000 1,188,000 -3,265,000 2,279,000 344,000                     
          net increase in cash and cash equivalents
        65,829,000    194,729,000 862,333,000 -87,583,000 -62,925,000 170,620,000 53,386,000 114,393,000 286,429,000 42,124,000 128,093,000 220,430,000 -100,613,000 -80,332,000 -219,620,000 -1,206,133,000 1,039,764,000 315,827,000 -44,140,000 84,480,000 64,258,000 -157,831,000 157,436,000 90,273,000 237,844,000 -189,396,000 13,937,000 31,912,000 67,134,000     -604,000 -501,399,000 -111,814,000 -9,005,000 -10,074,000 77,216,000 139,040,000 98,561,000 109,002,000 306,785,000 22,381,000 -390,630,000 48,042,000 84,155,000 53,796,000 63,315,000 197,403,000 35,250,000 -16,111,000 88,578,000 -19,139,000 -1,181,000 37,335,000 20,267,000 21,941,000   3,403,000     -25,004,000 -1,295,000   -17,027,000 -28,028,000 
          cash and cash equivalents, at beginning of period
        2,412,864,000 1,506,310,000 881,482,000 591,448,000 1,057,769,000 637,344,000 309,622,000 386,035,000 365,963,000 988,785,000 684,042,000 636,504,000 387,196,000 82,076,000 44,794,000 15,595,000 24,903,000 102,945,000 
          cash and cash equivalents, at end of period
        65,829,000 136,190,000 -672,066,000 1,861,946,000 194,729,000 862,333,000 -87,583,000 1,443,385,000 170,620,000 53,386,000 114,393,000 1,167,911,000 42,124,000 128,093,000 220,430,000 490,835,000 -80,332,000 -219,620,000 -1,206,133,000 2,097,533,000 315,827,000 -44,140,000 84,480,000 701,602,000 -157,831,000 157,436,000 90,273,000 547,466,000 -189,396,000 13,937,000 31,912,000 453,169,000 133,420,000 13,402,000 -107,782,000 346,995,000 -604,000 -501,399,000 -111,814,000 979,780,000 -10,074,000 77,216,000 139,040,000 782,603,000 109,002,000 306,785,000 22,381,000 245,874,000 48,042,000 84,155,000 53,796,000 450,511,000 197,403,000 35,250,000 -16,111,000 170,654,000 -19,139,000 -1,181,000 37,335,000 65,061,000 21,941,000 13,279,000 -9,424,000 18,998,000 3,365,000 -3,542,000 -1,243,000 17,015,000 -25,004,000 -1,295,000 -49,569,000 100,771,000 -17,027,000 -28,028,000 
          supplemental disclosure of cash flow information:
                                                                                  
          cash paid for interest
                                                                              4,554,000 3,616,000   
          cash paid for income taxes, net of refunds
                                                                                  
          prepaid expenses and other current assets
         -6,674,000 -28,065,000 36,277,000 9,866,000 -34,164,000 -20,075,000 54,947,000 -88,852,000 -33,935,000 -45,424,000 42,032,000 11,987,000 1,147,000 -516,000 23,170,000 -48,598,000 -13,371,000 -18,454,000 -2,897,000 -33,140,000 -20,049,000 -27,010,000 -17,843,000 -2,792,000 -6,929,000 -14,941,000 -988,000 -292,000 12,257,000 -1,734,000 -3,534,000 -16,284,000 -9,720,000 9,767,000 -10,637,000 -7,188,000 1,823,000 -9,104,000 -1,231,000 9,018,000 8,378,000 1,994,000 -15,670,000 7,674,000 3,326,000 -3,421,000 4,357,000 -2,571,000 3,372,000 -8,400,000 -6,272,000 -9,248,000 1,547,000 -3,173,000 -2,217,000 117,000 769,000 -978,000 -842,000 817,000 121,000 173,000 -685,000 1,571,000 258,000 522,000 259,000 949,000 193,000 500,000 -951,000 361,000 -764,000 
          operating lease assets
         3,178,000 6,527,000 5,913,000 6,414,000 3,498,000 3,496,000 3,703,000 525,000 2,845,000 7,070,000 4,508,000 4,097,000 3,733,000 3,844,000 3,095,000 3,529,000 4,161,000 4,203,000 3,690,000 2,636,000 3,308,000 3,227,000 3,195,000 3,229,000 3,520,000                                                 
          other non-current assets
         18,824,000 -50,000 -752,000 -40,276,000 -3,845,000 -1,609,000 -4,090,000 4,997,000 -7,973,000 -3,367,000 -9,541,000 -20,032,000 -3,677,000 -1,308,000 979,000 2,654,000 -1,664,000 -330,000 157,000 7,972,000 11,959,000 1,659,000 323,000 -17,081,000 1,557,000 268,000 426,000                                               
          operating lease liabilities, less current portion
         -3,475,000 -1,797,000 -1,090,000 -15,040,000 -2,792,000 -3,929,000 -2,980,000 -3,110,000 -1,905,000 -6,991,000 -4,959,000 -4,283,000 -4,054,000 -4,170,000 -3,915,000 -2,614,000 -4,633,000 -4,608,000 -4,182,000 -2,499,000 -2,906,000 -3,072,000 -3,906,000 -2,907,000 -3,568,000                                                 
          other non-current liabilities
         529,000 792,000 3,971,000 -14,851,000 2,161,000 1,990,000 -3,831,000 -26,671,000 1,200,000 17,465,000 1,835,000 -18,163,000 -4,295,000 5,932,000 5,130,000 -21,425,000 5,136,000 6,569,000 4,774,000 -42,221,000 7,342,000 18,596,000 7,316,000 7,195,000 -17,811,000 7,404,000 6,773,000 7,293,000 -6,711,000 6,304,000 7,651,000 6,003,000 -2,602,000 7,359,000 8,174,000 4,847,000 3,765,000 7,195,000 7,392,000 8,093,000 5,198,000 6,451,000 6,820,000 4,814,000 4,449,000 3,772,000 4,689,000 4,695,000 3,416,000 3,513,000 3,196,000                       
          net decrease in cash and cash equivalents
          -672,066,000 -550,918,000                              13,402,000 -107,782,000 -18,968,000                              -3,542,000 -1,243,000 -7,888,000    -2,174,000   
          net loss
           -92,541,000                                                             5,653,000 -1,672,000 2,171,000 -12,988,000 -56,940,000 -28,810,000 -51,879,000 -46,710,000 -60,020,000 -19,359,000 
          adjustments to reconcile net loss to net cash from operating activities:
                                                                                  
          intangible asset impairment charge
                                                                                  
          loss on disposal of a business
                    -1,554,000 -1,556,000                                                             
          deferred revenue
                -4,000 -459,000 -523,000 -523,000 -524,000 -523,000 -697,000 -697,000 -274,000 -637,000 -1,180,000 -1,180,000 -1,180,000 -1,180,000 -1,180,000 -1,180,000 -1,180,000 -1,874,000 -1,874,000 -1,874,000 -1,874,000 -1,875,000 -2,154,000 -2,157,000 -2,170,000 27,490,000 -633,000 -206,000 -210,000 -266,000 123,000 -277,000 -97,000 -285,000 -285,000 -361,000 -284,000 -273,000 -285,000 -284,000 -285,000 -207,000 -1,157,000 -298,000 535,000 -285,000 -284,000 -513,000 -479,000 3,000 -2,424,000 -296,000 -69,000 249,000 -110,000 -134,000 -10,540,000 -2,000 -362,000 8,685,000 1,652,000 -285,000 -789,000 -313,000 
          proceeds from sale of a business
                                                                                
          net proceeds from issuance of exchangeable senior notes, due 2030
                                                                                  
          repayment of exchangeable senior notes, due 2024
                                                                                  
          deferred tax expense
                    -145,377,000 -64,559,000                                                             
          acquisition of a business, net of cash acquired
                                                                                
          net proceeds from issuance of borrowings under credit agreement
                                                                                
          net proceeds from issuance of senior secured notes, due 2029
                                                                                
          payments for repurchase of exchangeable senior notes, due 2021
                                                                                 
          impairment charge
                            136,139,000                                                   
          distributions from equity method investees
                                                                                  
          net proceeds from issuance of exchangeable senior notes, due 2026
                                                                                
          net proceeds from revolving credit facility
                                                                                  
          repayments under revolving credit facility
                                      -500,000,000 -200,000,000 -150,000,000     -80,000,000                                 
          net proceeds from sale of assets
                                    -194,000                                              
          deferred tax provision
                         -74,994,000                                                         
          payments for partial repurchase of exchangeable senior notes, due 2021
                            -23,300,000                                                     
          amortization of debt discount and deferred financing costs
                           15,688,000 16,046,000 15,820,000 12,793,000 12,000,000 11,981,000 11,831,000 11,451,000 11,133,000 11,291,000 11,165,000 10,887,000 10,617,000 10,792,000 7,855,000 5,764,000 5,615,000 5,715,000 5,642,000 5,414,000 5,362,000 5,390,000                                  
          impairment charges
                                                                                
          loss on extinguishment and modification of debt
                                                                           
          proceeds from revolving credit facility
                                                                                
          proceeds from tenant improvement allowance on build-to-suit lease
                                                                                
          loss on extinguishment of debt
                             614,000                                   150,000                  
          acquisitions, net of cash acquired
                                                   -828,676,000                         
          loss on disposal of assets
                               73,000 13,000 1,000 4,000 3,000 3,000                                              
          net proceeds from issuance of debt
                                        -91,000    -130,000    -318,000 -2,043,000   -981,000 559,011,000 636,355,000                       
          deferred income taxes
                                     -12,430,000 -16,921,000 -15,307,000 -172,232,000 -23,403,000 -14,956,000 -15,000,000 -24,701,000 -15,410,000 910,000 -1,962,000 -35,841,000 -8,495,000 -7,612,000 -9,261,000 -7,177,000 -17,648,000 -14,220,000 -4,378,000 7,865,000 -8,898,000 -5,190,000 -3,874,000                       
          other long-term assets
                                     -2,911,000 405,000 -3,988,000 1,944,000 442,000 -97,000 -2,170,000 5,187,000 -524,000 -2,411,000 -1,985,000 -2,167,000 -2,897,000 -3,380,000 -3,278,000 -3,116,000 -2,410,000 -1,820,000 -1,545,000 -885,000 -804,000 -1,618,000 -999,000 -1,194,000                      
          loss on disposal of property, plant and equipment
                                      -141,000 256,000                                           
          loss on disposal of property and equipment
                                        113,000 -97,000 375,000 82,000 44,000 -34,000 37,000 55,000 71,000 38,000 8,000    2,000 -1,000 7,000 40,000 17,000 7,000   18,000   -34,000    5,000 9,000 830,000   
          purchases of property and equipment
                                        -8,878,000 -8,347,000 -8,151,000 -3,574,000 -1,277,000 -2,382,000 -1,701,000 -2,472,000 -3,367,000 -5,159,000 -13,022,000 -14,410,000 -13,548,000 -8,139,000 -11,133,000 -3,527,000 -3,102,000 -2,164,000 -3,567,000 -1,143,000 -983,000 -2,499,000 -2,209,000 -285,000 -756,000 -362,000 -95,000 -66,000 -113,000 -316,000 -216,000 -86,000 -6,000 -30,000 -12,000 -5,000 -74,000 -56,000 -1,151,000 -458,000 -1,043,000 -593,000 
          net proceeds from sale of business
                                                1,000,000 32,703,000                               
          acquisition of noncontrolling interests
                                                -13,000    -19,000 -310,000 -17,465,000 -119,175,000                           
          acquisition of in-process research and development
                                            -15,000,000 -8,750,000     -626,000 -75,000,000 -2,000,000 -125,000,000                           
          proceeds from employee equity incentive and purchase plans and exercise of warrants
                                           5,676,000     6,498,000 7,295,000   10,035,000 16,810,000 10,175,000 21,467,000 7,126,000 8,114,000                         
          acquisition accounting inventory fair value step-up adjustments
                                                    2,455,000 8,022,000                           
          contingent consideration
                                                    -14,900,000                           
          payment of contingent consideration
                                                    -35,100,000                           
          excess tax benefit from share-based compensation
                                              4,435,000 -7,938,000    -10,635,000 2,234,000 -3,283,000 4,985,000 -5,777,000 255,000   -889,000 -5,519,000 1,972,000 -4,324,000 -1,914,000                   
          proceeds from employee equity incentive plans
                                               3,780,000                                   
          change in fair value of contingent consideration
                                                        2,300,000 5,000,000 3,400,000 4,500,000 -1,400,000 900,000                     
          proceeds from employee equity incentive plans and exercise of warrants
                                                   13,504,000                               
          amortization of intangible assets
                                                    31,977,000 30,630,000 32,795,000 31,182,000 20,524,000 19,564,000 19,399,000 19,555,000 21,908,000 21,750,000 15,751,000 13,513,000 1,862,000 1,862,000 1,862,000 1,862,000 1,862,000 1,862,000 2,044,000 2,057,000 2,057,000 2,057,000 1,822,000 1,732,000 3,374,000 3,488,000 3,845,000 2,121,000 2,280,000 2,288,000 
          gain on sale of business
                                                                                  
          liability under government settlement
                                                            -7,320,000 95,000 95,000 -1,072,000 -2,904,000 126,000 123,000 121,000 -2,876,000 -2,346,000        
          purchases of marketable securities
                                                            -6,815,000 -30,628,000 -67,751,000                  
          proceeds from sale of marketable securities
                                                            66,164,000 15,082,000                   
          proceeds from maturities of marketable securities
                                                            14,150,000 17,838,000         1,004,000 25,000 501,000     
          purchase of product rights
                                                            -5,750,000 -1,250,000 -8,250,000 -1,250,000 -1,125,000 -1,125,000 -1,125,000 -1,125,000 -1,000,000 -1,000,000 -1,000,000 -1,000,000    -1,000,000 -7,000,000      
          intangible asset impairment
                                                                                 
          repayment of long-term debt
                                                      -2,505,000 -2,299,000 -1,393,000 -1,393,000 -457,186,000 -5,938,000 -5,937,000                     
          decrease in restricted cash
                                                                                 
          payments of debt extinguishment costs
                                                                -150,000                  
          net repayments under revolving credit facility
                                                                                  
          acquisition accounting inventory fair value step-up
                                                         512,000 1,086,000 1,545,000                       
          cash acquired from merger with azur pharma
                                                               81,751,000                   
          purchases of intangible assets
                                                           -1,300,000                       
          proceeds from exercise of share options and warrants
                                                           9,609,000                       
          proceeds from employee share purchases, exercise of share options and warrants
                                                                                  
          payment of employee withholding taxes upon exercise of share-based awards
                                                            -25,299,000                   
          proceeds from offerings of common stock, net of issuance costs
                                                                                  
          share-based compensation expense
                                                             6,612,000 5,258,000 3,281,000                   
          purchase accounting inventory fair value step-up
                                                             11,442,000                     
          movement in deferred income taxes
                                                                                  
          other long-term liabilities
                                                                                  
          proceeds from employee stock purchases, exercise of stock options and warrants
                                                             2,422,000   2,951,000 4,057,000                 
          other assets and liabilities
                                                              -892,000 -299,000                   
          proceeds from exercise of stock options and warrants
                                                               5,160,000    4,526,000               
          net repayments under revolving credit facilities
                                                                 -4,000,000 -3,350,000               
          stock-based compensation expense
                                                                10,946,000 3,195,000 3,415,000 3,148,000 2,250,000 2,177,000 1,960,000 1,832,000 2,448,000 1,313,000 1,114,000 1,082,000 2,316,000 1,688,000 1,875,000 2,227,000 2,287,000 1,793,000 
          long-term debt, non-cash interest expense
                                                                188,000 206,000 231,000              
          other assets
                                                                -4,000 69,000    -101,000   -731,000 247,000 -517,000 -4,000 261,000 160,000 -269,000 -232,000 304,000 -266,000 
          deferred rent
                                                                -12,000 -65,000 -5,000 -4,000 13,000 22,000 22,000 22,000        -85,000 -75,000 
          proceeds from issuance of long-term debt
                                                                                  
          net (repayments under) proceeds from revolving credit facilities
                                                                                  
          supplemental disclosure of non-cash investing and financing activities:
                                                                                  
          liability for purchase of product rights
                                                                                
          warrants to purchase common stock
                                                                                  
          modification to warrants to purchase common stock issued in conjunction with long-term debt
                                                                                  
          decrease in restricted cash and investments
                                                                    510,000 41,000 2,037,000 -2,038,000 125,000 -300,000 1,138,000 85,000 11,941,000 -1,550,000  
          repayment of senior secured notes
                                                                    -116,496,000 -3,000,000          
          proceeds from term loan
                                                                    -261,000             
          repayment of term loan
                                                                  -4,166,000 -4,166,000 -4,166,000              
          gain on sale of product rights
                                                                               -715,000 
          transfer of restricted cash to marketable securities
                                                                                  
          proceeds from sale of product rights
                                                                               1,150,000 
          prepayment penalties and fees
                                                                                  
          proceeds from employee stock purchases and exercise of stock options and warrants
                                                                                  
          proceeds from sale of senior secured notes and warrants, net of issuance costs
                                                                            -28,000 -634,000 39,200,000   
          modification to warrants to purchase common stock issued in conjunction with senior secured notes
                                                                                  
          loss on extinguishment of debt, non-cash portion
                                                                                 
          proceeds from offering of common stock, net of issuance costs
                                                                     -302,000             
          proceeds from private offerings, net of issuance costs
                                                                                  
          proceeds from employee stock purchases and exercise of stock options
                                                                     67,000   236,000 25,000   192,000     
          net repayment of revolving credit facilities
                                                                                 
          warrants to purchase common stock issued in conjunction with unregistered sales of equity securities
                                                                                 
          senior secured notes, non-cash interest expense
                                                                      873,000 1,050,000  701,000         
          senior secured notes, accrued and unpaid interest
                                                                                  
          proceeds from exercise of employee stock options
                                                                       511,000           
          net repayment of revolving line of credit
                                                                       -1,559,000           
          fair value adjustment to acquired finished goods
                                                                                
          revaluation of preferred stock warrant liability
                                                                                
          senior secured notes
                                                                                  
          net proceeds from line of credit
                                                                                  
          warrants to purchase common stock issued in conjunction with registered direct public offering
                                                                                 
          warrants to purchase common stock issued in conjunction with senior secured notes
                                                                                
          warrants to purchase common stock issued in conjunction with equity financing facility
                                                                                
          purchases of product rights
                                                                         -2,000,000         
          net repayments of line of credit
                                                                                  
          proceeds from public offerings, net of issuance costs
                                                                                  
          common stock issued as employee bonuses
                                                                                 
          accrued unpaid interest on senior secured notes
                                                                                  
          provision for government settlement
                                                                          149,000 62,000    -1,818,000   
          net (repayments of) proceeds from line of credit
                                                                                  
          accrued unpaid interest for senior secured notes
                                                                           5,078,000       
          proceeds from exercise of stock options
                                                                               2,000   
          repayment under line of credit
                                                                           -3,875,000       
          interest on development financing
                                                                                  
          gain on extinguishment of development financing
                                                                                  
          proceeds from sale of property and equipment
                                                                                  
          proceeds from maturites of long-term restricted cash equivalents
                                                                                  
          proceeds from issuances of convertible preferred stock, net of issuance costs
                                                                                  
          proceeds from line of credit
                                                                              6,100,000 3,179,000 4,307,000 3,308,000 
          proceeds from development financing
                                                                                  
          beneficial conversion feature - deemed dividend attributable to preferred stockholders
                                                                                  
          transfer of long-term restricted investments to marketable securities
                                                                             -4,410,000   
          proceeds from sale of common stock in initial public offering, net of issuance costs
                                                                                 -650,000 
          net (repayments under) proceeds from line of credit
                                                                                  
          proceeds from sale of common stock in registered direct public offering, net of issuance costs
                                                                                  
          supplemental disclosure of non-cash financing and investing activities:
                                                                                  
          conversion of preferred stock warrant liability to stockholders’ equity
                                                                                 
          purchased product rights liability
                                                                                  
          purchase of developed technology
                                                                              -10,000,000 -10,000,000   
          repayments under line of credit
                                                                              -3,181,000 -3,458,000 -3,445,000 -3,845,000 
          supplemental disclosure of non-cash financing activities:
                                                                                  
          fair value of warrants granted under 40.0 million senior notes
                                                                               2,000,000   
          purchased in-process research and development
                                                                                  
          purchases of available-for-sale securities
                                                                                  
          proceeds from sales of available-for-sale securities
                                                                                  
          proceeds from maturities of available-for-sale securities
                                                                                  
          cash paid for shares of orphan medical, inc., net of cash acquired
                                                                                  
          proceeds from maturites of long term restricted cash equivalents
                                                                                  
          proceeds from initial public offering
                                                                                  
          proceeds from sale of senior secured notes, net of issuance costs
                                                                                  
          warrants to purchase series bb convertible preferred stock issued in conjuction with senior secured notes
                                                                                  
          beneficial conversion feature—deemed dividend attributable to preferred stockholders
                                                                                  
          depreciation and amortization
                                                                                 332,000 
          excess of cash paid over accrued for interest
                                                                                 315,000 
          gain on extinguishment of development financing obligation
                                                                                  
          proceeds from issuances of common stock, net of issuance costs
                                                                                 
          increase in restricted cash and investments